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Introduction: The incidence of Clostridium difficile infection has been steadily rising, 
growing in virulence, and demonstrating an increase in the severity and morbidity of the 
disease.  A clinical prediction rule (risk score), applied early in, or prior to, 
hospitalization is a strategy to identify vulnerable patients, target preventative 
interventions, improve outcomes for Clostridium difficile infection, and translate 
evidence into clinical practice. Objectives: The purpose of this research was to develop 
and validate a clinical prediction rule for the risk of Clostridium difficile infection.  
Methods:  Between August 2007 and June 2009, preoperative variables and positive 
Clostridium difficile assays were collected for adult patients admitted for surgical 
colectomy from 24 hospitals in Michigan. After performing univariate analysis of 36 
preoperative patient risk factors, significant variables associated with Clostridium difficile 
infection at a p value ≤ .15 were advanced into a binary logistic regression model.  The 
regression coefficients of this model were translated into a weighted scoring system to 
develop the clinical prediction rule.  The Receiver operating characteristic curve analysis 
evaluated the predictive accuracy of the score.  Results:  2274 patients underwent 
colectomy and fulfilled inclusion criteria.  A total of 55 patients (2.4% overall) developed 
Clostridium difficile infection.  Mechanical ventilation (p=.012) and a history of a 
transient ischemic attack (p=.042) were independently associated with Clostridium 
difficile infection.  A clinical prediction rule, including the variables from the final model, 
demonstrated a larger score with an increased patient risk (p ≤ .01).  The area under the 
  xiv 
receiver operating characteristic curve was 0.628 (95% CI .550 -.706).  Conclusions:  
Pulmonary and neurological morbidities emerged as significant preoperative predictive 
variables of Clostridium difficile infection in this cohort. In contrast to previous studies, 
bowel preparation, with and without antibiotics, was not associated with an increased risk 
of CDI.  Findings from this study suggest pathogen-directed interventions, such as a 
clinical prediction rule to quantify the risk factors of Clostridium difficile infection, may 
offer a promising adjunctive strategy to reduce infection and protect vulnerable patient 
populations.  
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Chapter I  
 
Introduction 
 The 2000 Institute of Medicine report, ―To Err is Human ―(Institute of Medicine, 
2000), galvanized a national effort to reduce medical errors and put the pressure on 
healthcare organizations to improve patient safety (Yokoe & Classen, 2008).  Nearly a 
decade later, patient safety is a top priority at the local, national and global level (Pittet & 
Donaldson, 2005).  Although the transformation to a safer patient environment has 
advanced significantly, the challenges of moving healthcare closer to a state of 
flawlessness is still well beyond the reach of most hospitals (Sprague, 2009).  The patient 
safety movement, which has been progressive, but slow, is now summoning greater 
government involvement, oversight and mandates.  
In 2008, the Centers for Medicare and Medicaid Services (CMS) began 
implementing its landmark decision to restrict reimbursing hospitals for the cost of 
preventable patient injury and infection (Centers for Medicare and Medicaid Services, 
2009).  This decision is intended to save the government billions of dollars, drive patient 
safety initiatives and spur healthcare reform to address medical errors.  The widespread 
impact of this decision will likely have marginal financial repercussions on the relatively 
rare medical errors such as operating on the wrong limb or infusing incompatible blood 
(Fuhrmans, 2008).  However, the decision to impose financial penalty on the more 
commonplace patient injuries such as pressure ulcers, falls and health care-associated 
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infection is already shifting the traditional view of hospital complications from that of an 
inevitable consequence of hospitalization to that of an entirely preventable event.   
 This could have an especially profound impact on the various preventable hospital 
infections generically termed health care-associated infection (HAI).  Although accounts 
in the popular press frequently emphasize medication errors, patient falls or surgical 
errors in the discussion of patient safety, an HAI is the most common adverse event a 
patient will encounter during hospitalization (Gasink & Lautenback, 2008; Haley, Culver, 
White, Morgan, & Emori, 1985).  HAI is the cause of an estimated 2 million infections 
and 100,000 deaths annually (Klevens, et al., 2007) which translates into approximately 
5-10% of all hospitalized patients (Weinstein, 1998).  This prevalence has led experts to 
predict HAI will be one of the primary medical and public health problems in the United 
States in the near future (Nelson, K. E. & Williams, 2007).  This prediction is also due, at 
least in part, to the steady increase in the aging population, the ability of modern 
medicine to continue to devise technologies that prolong life and the emergence of 
dangerous pathogens resistant to traditional antimicrobial treatment (Nelson, K. E. & 
Williams, 2007; Yokoe & Classen, 2008). 
 The financial consequences associated with HAI are considerable.  The United 
States Department of Health and Human Services (HHS) report that the cost of HAIs are 
as much as $20 billion dollars annually (Klevens, et al., 2007).  Other more recent 
estimates, adjusted for inflation, and taking into account the resources required in order to 
prevent infection, placed the price tag between 5.7 billion and 6.8 billion in direct patient 
costs (Scott, 2009). Even this conservative estimate of the direct medical costs of HAI 
rival the annual cost of treating stroke (6.7 million), diabetes with complications (4.5 
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million) and chronic obstructive lung disease ( 4.2 million) (Levit, Stranges, Ryan, & 
Elixhauser, 2008).  Thus, preventing HAI is clearly a fiscal strategy deserving of 
adequate investment and resources.  
 Less often described but of equal importance is the human cost of HAI.  The 
indirect costs (lost wages, unpaid leave) and the intangible costs (emotional distress, 
disfigurement, and pain) (Scott, 2009) generate a human cost that may be difficult to 
measure, but can exact a significant human toll - a toll that no patient wants to pay, to 
which no clinician will knowingly want to contribute and to which no hospital wants to 
be deemed an accessory.  It is clear that strategies to eradicate infection summed up in the 
phase ―chasing zero‖ (Cardinal Health, 2008) is the only appropriate goal if a true culture 
of patient safety is to be achieved (Sprague, 2009). 
This research is the foundation for the investigation of a clinical prediction rule as 
a novel strategy to reduce the impact of unnecessary HAI.  It opens with a review of the 
current strategies used to prevent and control HAI currently in practice and then discusses 
the definition, methodology and application of clinical prediction rules as a potential 
effective adjunct to these strategies.  To contextualize the investigative strategy, a 
conceptual framework of HAI risk is proposed and a working model presented.  Chapter 
II focuses on one of the most serious offending HAI organisms, Clostridium difficile (C. 
difficile) which recently passed methicillin-resistant Staphylococcus aureus (MRSA) as 
the most common HAI in the United States (Dubberke, et al., 2008; McDonald, Owings, 
& Jernigan D., 2006) and therefore has both timely and practical significance as a focus.  
Chapter III defines the research methods and procedures followed by the presentation of 
the results (in Chapter IV).  The closing chapter discusses the research findings and the 
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clinical implications for practice and future research in order to help abolish HAI caused 
by C. difficile – one of the most common, problematic, and avoidable adverse outcomes 
patients are likely to have during the course of their hospitalization 
Health Care-Associated Infections: Defined 
An HAI is an infection that afflicts a patient while receiving treatment in a health 
care environment (Horan, Andrus, & Dudeck, 2008).  Sometimes referred to as 
nosocomial infections or hospital-acquired infections, HAI is the broader, more 
appropriate term to reflect the changing patterns in healthcare delivery where patients 
may receive care in outpatient surgical centers, ambulatory clinics, and long term care 
facilities, not only hospital centers (Burke, 2003; Siegel, Rhinehart, Jackson, Chiarello, & 
Healthcare Infection Control Practices Advisory Committee, 2007).  The most significant 
HAIs are attributed to the specific organisms of MRSA and C. difficile and those 
associated with devices or procedures such as central line-associated bloodstream 
infections (CLABSI), ventilator- associated pneumonia (VAP), catheter-associated 
urinary tract infection (CAUTI) and surgical site infection (SSI) (Sprague, 2009).    
Key factors in the cause of HAI.  Despite the national attention on HAIs in the 
United States, the incidence of HAI continues to plague most hospital organizations. This 
may be due in part to better reporting and detection, but this alone is insufficient to 
explain the problem.  One possible explanation is that the over-prescribing of antibiotics 
has caused a generation of multidrug-resistant organisms (MDROs) or ―superbugs‖ that 
have evolved a resistance to the standard antimicrobial treatment.  The number of such 
organisms has risen sharply over the last decade and organisms are even harder to detect 
and treat (Gasink & Lautenback, 2008; Tenover, 2001). Described as the microscopic 
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illustration of the dictum ―What doesn‘t kill you makes you stronger,‖ (Sprague, 2009, p. 
4), pathogens that evolve from resistance to antibiotics thrive and persist during 
traditional antimicrobial treatment regimes.  The growth in MDROs comes at a time 
when the development of new antimicrobial agents targeting these organisms, has 
decreased by about 56% (Gasink & Lautenback, 2008; Spellberg, Powers, Brass, Miller, 
& Edwards, 2004). 
Being that the most rapidly rising segment of the population in the United States 
are those 85 years of age and older (Fried, 2003), and those are more likely to have a 
compromised immune system due to underlying diseases (Nelson, K. E. & Williams, 
2007), this subset of the population is especially vulnerable to an adverse outcome of 
HAI.  To illustrate, a recent study investigating the prevalence of C. difficile infection 
found that among the elderly the risk of infection was as much as 20-fold higher than 
among adult patients under the age of 45 (McDonald, et al., 2006).  Clearly, the 
disproportionate impact of HAI on the older segment of the population will continue to 
be an area of concern. 
Another major cause in the rise of HAI, is unintentional exposure to the pathogen 
in the health care environment (Nelson, K. E. & Williams, 2007).  The transmission of 
pathogens is aided by the exposure of contaminated equipment, the proximity of 
uninfected patients to colonized patients and the likelihood that a health care worker did 
not adhere to prescribed hand hygiene policies.  This cause is especially important in 
light of the rise of the sophistication of health care monitoring and the increased use of 
indwelling catheters and other medical devices (Nelson, K. E. & Williams, 2007).  
Furthermore, in a health care industry that is operating in an era of constrained resources 
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and manpower, the environment may be further compromised and vulnerable patients 
further exposed to unintended transmission of pathogens (Nelson, K. E. & Williams, 
2007).   
Hospital practices to prevent HAI.  At the organizational level, hospital-based 
infection control, prevention and surveillance programs have been at the epicenter of 
efforts to control, detect and monitor HAIs (Yokoe & Classen, 2008).  The cornerstone of 
these programs is the enforcement and monitoring of basic hygiene, the first line of 
defense against HAI.  This includes decontaminating surfaces that an infected person 
may have contaminated, cleaning of supplies and equipment for re-use by other patients 
and the most important of hygiene practices, decontamination of the hands.  A 
comprehensive compendium of evidence-based recommendations for hand hygiene is 
published by the Centers for Disease Control and Prevention‘s federal advisory board, the 
Healthcare Infection Control Practices Advisory Committee (HICPAC) (Boyce & Pittet, 
2002).  Despite this relatively simple intervention, adherence to hand hygiene standards is 
typically low (Larson, 1988) and although the addition of alcohol-based hand hygiene has 
helped to improve adherence (less time to perform, less skin irritation, convenient) 
(Boyce, Kelliher, & Vallande, 2000), sustained improvements are still difficult to achieve 
(Gasink & Lautenback, 2008).  The next line of defense for HAI is the initiation of 
barrier precautions and/or isolation precautions (Siegel, et al., 2007).  Tiered precautions, 
based on the offending infection and organism, are detailed and specific and range on a 
scale from routine standard precautions to the most heightened precaution, isolation.   
Another preventive measure is the implementation of antimicrobial stewardship 
programs.  The objective of these programs is the reduction of unnecessary antimicrobial 
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use (Owens, Donskey, Gaynes, Loo, & Muto, 2008).  This is significant because 
emerging evidence has revealed the duration of antimicrobial use and the concomitant 
use of multiple antimicrobials to confound the risk for developing HAI (Owens, et al., 
2008).  Although additional research is needed regarding the specific strategies for the 
prevention and containment of MDROs (Dellit, et al., 2007), the practice of effective 
antimicrobial stewardship programs, in concert with environmental control strategies, is 
regarded as critical for the reduction of HAI (Dubberke, et al., 2008; Fowler, et al., 2007; 
Gerding, Muto, & Owens Jr., 2008).  
The idea of leveraging technology in the fight against infection began over 20 
years ago in an effort to devise ―clinical triggers‖ to enhance the detection and 
surveillance of infection (Burke, 2003; Burke, Classen, Pestotnik, Evans, & Stevens, 
1991; Evans, et al., 1992)  For instance, the HELP (Health Evaluation through Logical 
Processing) hospital information system was used to automate the surveillance and 
analysis of hospital-acquired infections, provide reminders for prophylactic antibiotic 
administration and identify patients at high risk for nosocomial infection (Burke, et al., 
1991).  Now more sophisticated technology such as the MedMined, Inc. (Cardinal 
Health, 2009) and TheraDoc (Theradoc Inc., 2009) are enabling hospital clinicians to 
analyze data from patients more rapidly than ever before.  These and other electronic 
surveillance systems can detect overuse or misuse of antibiotics, prescribing histories and 
identify infection ―clusters‖ within hospitals and units.  Although promising new 
strategies for the prevention and surveillance of infection, they still fall short as a 
mechanism for identifying at-risk patients for unit level interventions.   
  8 
Some of the most successful accounts of reducing HAI implemented a 
multifaceted, multidisciplinary and multimodal intervention approach.  For example, the 
implementation of several evidenced-based interventions simultaneously ―bundled‖ 
together in the effort to decease CLABSI demonstrated a substantial reduction in overall 
CLABSI rates (Pronovost, et al., 2006).  The implementation of similar approaches is 
underway to reduce SSI and VAP (Institute for Healthcare Improvement, 2009).  
Checklists are gaining momentum as means to implement ―bundles‖ and combine 
healthcare worker education in tandem with simple and easy to follow multidisciplinary 
detection, surveillance and control procedures (Abbett, et al., 2009).  Others have 
reported state-wide collaborative efforts as a means to monitor, trend and recommend 
practice-based solutions (Share, et al., 2011).  These strategies underscore the basic but 
innovative approaches of challenging the existing clinical practices to fight HAI. 
The overall strategy on how to best implement the interventions is just as 
important as the intervention itself.  For example, infection control interventions that are 
tailored to a specific organism, such as C. difficile, are called pathogen-directed or 
(vertical) interventions (Jernigan, 2011; Wenzel & Edmond, 2010).  These interventions 
are designed to prevent transmission of the specific pathogen causing the infection.  In 
contrast, the non-pathogen directed, or the horizontal intervention approach, attempts to 
reduce the rates of all infections, from all pathogens, simultaneously (Harris, 2011; 
Wenzel & Edmond, 2010).  The advantages and disadvantages of both infection control 
approaches is a topic of recent debate (Harris, 2011; Jernigan, 2011; Wenzel & Edmond, 
2010).  Advocates for the pathogen-directed approach argue the epidemiological 
characteristics of the organism must drive the interventions (Jernigan, 2011).  For 
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example, rapid screening and decolonizing of nasal carriers of Staphylococcus aureus on 
admission, has reported excellent success in the reduction of surgical site infections 
(Bode, et al., 2010).  Proponents of the non-pathogen directed approaches cite similar 
success rates using horizontal interventions with similar success rates at a significant cost 
savings (Harris, 2011; Wenzel, Bearman, & Edmond, 2008; Wenzel & Edmond, 2010).  
Although effective horizontal successes have been reported in relation to CDI infection 
(Abbett, et al., 2009), the magnitude and scope of the escalating CDI epidemic may prove 
to sufficiently challenge the current views of the horizontal infection intervention 
position. 
Despite whether or not the infection control strategy is implemented as a 
horizontal or vertical, the escalation of HAI continues to emerge as a serious medical and 
public health threat (Nelson, K. E. & Williams, 2007).  Long considered an inevitable 
part of hospitalization, HAI is now recognized as preventable, and therefore avoidable.  A 
rapidly growing elderly population, the emergence of new virulent pathogens, and the 
concern over resistance to traditional antibiotic regimens have elevated HAI prevention 
to a high priority on a national level (Yokoe & Classen, 2008).  Unfortunately, the 
incidence of HAI continues to grow (Burke, 2003) and the financial and human costs of 
HAI continue to mount (Scott, 2009).  The government‘s decision to withhold Medicare 
reimbursement for hospitals due to preventable patient injury and infection (Centers for 
Medicare and Medicaid Services, 2009) underscores the gravity of the problem and the 
―top-down‖ strategy necessary to address its prevalence.  
Although not currently available for clinical implementation, a clinical prediction 
rule to identify those at the greatest risk for HAI, may be a cost-effective, 
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nontechnological, and nonpharmaceutical approach to translate evidence-based research 
into clinical bedside practice.  Since nurses provide round-the-clock, direct patient care, 
they are uniquely positioned to prevent the HAI at the point of impact – the bedside.  And 
since the foundation of nursing practice is built upon a strong assessment, a logical 
extension of this practice would be to strengthen the assessment ability of nurses to detect 
those patients most vulnerable for the risk of HAI.  The addition of a clinical prediction 
rule CPR could move the nursing process ―upstream,‖ so that environmental challenges 
can be modified and /or individual defenses strengthened.  The following section 
provides more detail on clinical prediction rules and their clinical application to HAI. 
Clinical Prediction Rules 
Tools and models to predict clinical sequela have proliferated with the efforts to 
translate research evidence into clinical practice and the growth of an increasingly rich 
scientific base (Beattie & Nelson, 2006).  These tools, broadly termed clinical decision 
rules or clinical prediction rules, are defined as research-based tools where clinically 
relevant patient characteristics are quantified into numeric indices as a predictor of a 
specific disease, as a clinical necessity for treatment or for diagnostic testing (Beattie & 
Nelson, 2006; Randolf, Guyatt, Calvin, Dolg, & Richardson, 1998; Reilly & Evans, 
2006; Shapiro, 2005; Toll, Janssen, Vergouwe, & Moons, 2008).  Clinical prediction 
rules differ from clinical pathways or treatment algorithms in both the strict methodology 
of their development and the adherence to rigorous statistical testing (Shapiro, 2005).  
The number of published articles discussing prediction rules has more than doubled in the 
last decade (Toll, et al., 2008) reflecting the ability of clinical prediction rules to bring the 
most relevant  evidence-based practice to clinical bedside care (Jervis & McGinn, 2008).   
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Types of clinical prediction rules.  The term ―clinical prediction rule‖ is used 
interchangeably in the literature with the terms: (1) clinical decision rule (Shapiro & 
Driever, 2004) (2) prognostic score (Steyerberg, et al., 2008b), (3) scoring system 
(Scholz, Bäsler, Saur, Burchardi, & Felder, 2004; Schurink, et al., 2004), (4) risk index 
(Kheterpal, et al., 2009), (5) risk score (Ferro, et al., 2009), (6) severity score (Omachi, 
Yelin, Katz, Blanc, & Eisner, 2008) or tool (Woo, et al., 2009). The concomitant use of 
the term clinical decision rule with clinical prediction rule has recently come under 
increased scrutiny in the literature because the two terms have distinctly different 
outcomes; decision rules recommend diagnostic care or treatment where as prediction 
rules provide prognostic probability (Beattie & Nelson, 2006; Reilly & Evans, 2006).  
For example, the Ottawa Ankle Rule is a clinical decision rule to guide decisions of 
emergency department physicians regarding the necessity of radiographs for patients with 
ankle fractures (Shapiro & Driever, 2004).  In contrast, the Braden Scale for Pressure 
Ulcer Risk (Bergstrom, Braden, Laguzza, & Holman, 1987) predicts a patient‘s risk for 
developing a pressure ulcer, not a direct treatment recommendation.  For the purposes of 
this dissertation, the term clinical prediction rule (CPR) has been selected since it is the 
most widespread, descriptive and accurate term to investigate the risk of HAI (Ingui & 
Rogers, 2001).  
Clinical prediction rules are used routinely in clinical practice to identify patients 
at high risk for falls (Hendrich, 1989, 2007; Morse, 2006; Morse, Morse, & Tylko, 1989), 
pressure ulcers (Bergstrom, et al., 1987), and severity of disease (known as the Acute 
Physiology and Chronic Health Evaluation (APACHE) score) (Knaus, Draper, Wagner, 
& Zimmerman, 1985).  The prognostic utility and operational effectiveness of the 
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aforementioned prediction rules have been demonstrated to reduce cost, enhance patient 
safety (Hendrich, 2007; Morse, 2006) and standardize comparisons among and within 
health care organizations (Knaus, et al., 1985).   
Methodology of development.  Clinical prediction rules help guide and organize 
information, they are considered a special type of decision support tool (Shapiro 2004).  
And, because they are developed using strict methodological standards, rather than expert 
panels, they are designed to guide practice in a variety of settings and patient populations 
(Shapiro 2004).  The literature distinguishes three phases of clinical rule development in 
order to achieve satisfactory clinical validation: (1) development, (2) external validation 
and (3) clinical impact (Toll, et al., 2008).  Each phase provides a foundation for the next.  
For example, the first phase is considered critical for successful rule development since a 
carefully constructed, theoretically driven tool will help insure its internal validity 
(Shapiro, 2006).  Internal validity, in turn, will help ensure adequate external validity 
(Polit & Hungler, 1999; Shapiro, 2006).  Accurate clinical prediction depends on 
sequential testing of all three phases of prediction research to ensure the validity (internal 
and external), accuracy (calibration and discrimination) and necessary clinical impact 
analysis for successful implementation (McGinn, et al., 2000; Toll, et al., 2008).  
The methodology employed to develop, validate and test a clinical prediction rule 
is rigorous and specific to each phase of development.  During the initial phase of 
development, statistical analysis reveals which predictive values are the most robust and 
which can be eliminated from the rule without losing any predictive ability (McGinn, et 
al., 2000).  Typically these derivations are accomplished through logistical regression, 
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however, depending on the clinical situation, analysis may also include discriminate 
analysis, recursive partitioning analysis or neural networks (McGinn, et al., 2000).  
Although the use of univariate analysis can also be employed (McGinn, et al., 2000), only 
one predictor variable can be compared with the outcome, therefore limiting the full 
predictive ability of the rule.   
The validation phase is testing for the clinical accuracy of the clinical predictive 
tool and therefore, the population selected for validation should be different than the one 
used for rule derivation (Toll, et al., 2008).  Ideally, this validation should be conducted 
prospectively in a different population (Beattie and Shapiro 2006).  Two kinds of analysis 
should accompany validation studies: measures of accuracy (sensitivity, specificity and 
predictive values) and measures of agreement between raters (two examples being the 
kappa statistic or correlation coefficient (Shapiro, 2005).  Finally, during the last phase, 
the clinical prediction rule should be examined in relation to the full impact of how the 
clinical prediction rule will affect the outcome to include the change in behavior of the 
clinicians and the cost-benefit analysis (Toll, et al., 2008). 
Unfortunately, despite the abundance of published articles on clinical prediction 
rules, few actually achieve the necessary statistical rigor and clinical impact analysis 
necessary for the precision of implementation in the clinical environment (Reilly & 
Evans, 2006).  The degree of specificity and sensitivity inherent within the predictive 
model are imperative constructs to achieve in order to successfully and accurately 
predict, stratify or eliminate risk (Reilly & Evans, 2006).  Clinicians are cautioned against 
adoption of predictive variables that have not achieved these necessary evidentiary 
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standards (Reilly & Evans, 2006).  In a systematic review of four general medical 
journals, only half of the clinical prediction rules and clinical decision rules analyzed (21 
out of 41) met the criteria at a level of validation that could confidently be applied to 
clinical practice environments (Reilly & Evans, 2006). 
Clinical application for HAI.  Provided that the prediction rule has undergone 
the necessary methodological testing, statistical rigor and clinical impact analysis, 
prediction rules have the potential to systematically improve patient outcomes.  An 
accurate rule will improve patient care, streamline inconsistencies, demonstrate cost 
effectiveness and be practical to implement at the bedside (Shapiro, 2006).  Given the 
resources, expense and escalation of HAI, it is not surprising that two clinical prediction 
rules were located in the literature for this purpose.  Over the last decade, The National 
Nosocomial Infection Surveillance System Basic Surgical Site Infection Risk Index 
(NNIS SSI) has been applied as a strategy to reduce surgical wound infections and also 
serves to establish benchmarks for the prediction and comparison of surgical infection 
rates across hospitals (Bundy, Gonzalez, Barnard, Hardy, & DuPont, 2006; Emori, et al., 
1991).  The Clinical Pulmonary Infection Score (CPIS) is used to enhance the ability to 
predict the diagnosis of VAP in patients suspected of an infection (Kherallah, 2004; 
Pugin, et al., 1991).  Both have significant shortcomings (Ercole, Starling, Chianca, & 
Carneiro, 2007; Fartoukh, et al., 2003; Gaynes, et al., 2001); however, their contribution 
to advancing the science and pursuit of innovative strategies to prevent HAI is 
undisputable.   
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There are several recent reports of clinical prediction rules that have attempted to 
quantify different aspects of the HAI caused by C. difficile.  The majority of CPR‘s in the 
literature have focused on predicting the severity and morbidity of CDI (Belmares, 
Gerding, Tillotson, & Johnson, 2008; Bhangu, Bhangu, Nightingale, & Michael, 2010; 
Velazquez-Gomez, et al., 2008; Zar, Bakkanagari, Moorthi, & Davis, 2007).  This type of 
CPR was developed to help categorize a patients CDI status in order to choose the most 
effective therapeutic approach.  For example, the ATLAS severity score (based on a 
index of a patients age, temperature, leukocytosis, albumin and systemic concomitant 
antibiotics) helps physicians determine the best antibiotic treatment for patients based on 
whether or not they have mild, moderate or severe infection (Miller, 2011).  If a patient 
was categorized as having severe disease, vancomycin would be the treatment of choice, 
whereas, a patient categorized as having mild disease may benefit from metronidazole 
(Zar, et al., 2007).   
CPR‘s that aim to utilize the methodology further ‗upstream‘ to prevent CDI 
infection have received much less attention.  These CPR‘s are focused on the time before 
a patient gets an infection, not in response to the infection.  Kyne et al. (2002) was the 
first to describe how stratifying patients by a modified Horn‘s Index (a measure of 
underlying disease severity), could predict CDI in elderly, hospitalized patients on 
antibiotics (Kyne, Sougioultzis, McFarland, & Kelly, 2002).  A sequential two-predictor 
scoring system (antibiotic use and Horn‘s Index), identified 56% of CDI cases.  A later 
study using similar methodology, developed a CPR for recurrence of CDI (not initial 
infection) adding age and serum antitoxin A that predicted recurrent CDI with an 
accuracy of 69.2% (Hu, et al., 2008).  Garey et al. (2008) developed a more 
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comprehensive CPR based on two intrinsic (age, hemodialysis) and two extrinsic (non 
surgical admission and length of ICU stay) risk factors of disease (Garey, et al., 2008).  
Although the index demonstrated good discrimination (area under the ROC: 0.713-
0.712), it is limited in its ability to be applied on admission to the hospital because of its 
reliance on length of stay as a predictive variable since this is collected either at discharge 
or during hospitalization. 
In an innovative attempt to expand the use of a CPR already well integrated into 
practice, an adapted version of the Waterloo Risk Assessment for Pressure Ulcers was 
applied to an inpatient population as a measure to assess a patient‘s risk for CDI (Tanner, 
Khan, Anthony, & Paton, 2009).  It was hypothesized that the same subset of patients 
identified as high risk for pressure ulcers, could also be considered high risk for CDI.  
Utilizing an existing CPR already well integrated into practice, could prove an efficient 
use of resources, time and talent.  Although a small observation study and lacking in 
statistical rigor, the results suggested moderate success in validating the tool and 
predicting CDI (Tanner, et al., 2009).  More importantly, this research brings together 
two unlikely, albeit important, nursing priorities, preventing pressure ulcers and reducing 
infection.  Adapting an existing CPR‘s for use in a broader capacity could prove to be a 
resourceful method to increase efficient and decreasing adverse events.  This may be 
especially useful in patient areas where the standard infection prevention and control 
interventions are not working. 
With the move to electronic records and data collection, clinical prediction rules 
have been integrated into computerized clinical information systems as a strategy to 
detect patterns of related infection, monitor antimicrobial management and provide the 
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most up-to-date evidence-based practices (Bakken, et al., 2007; Cardinal Health, 2009; 
Shapiro, 2006; Theradoc Inc., 2009).  By leveraging the use of a collected repository of 
data, a series of computerized patterns can formulate electronic alerts much like the 
commercial process employs computer screening alerts to scan for credit card fraud.  
Although the medical informatics literature provides evidence of computer-assisted 
models for infection surveillance (Brossette, et al., 2006; Cardinal Health, 2009; Evans, 
et al., 1992; Theradoc Inc., 2009), the effectiveness for predicting at-risk patients for 
early clinical intervention at the point-of-care, not via infection control or administrative 
channels, is yet unclear. 
Pitfalls.  The overall goal of a clinical decision rule is to improve patient 
outcomes through a change in clinical practice.  However, clinical prediction rules are 
designed to augment and strengthen clinical acumen, not serve as a replacement for it.  
Claims that clinical expertise and simple intuition trump the objective measures of 
clinical prediction rules may be true to some extent (Randolf, et al., 1998).  Some studies 
have indeed found the intuition of experienced clinicians was just as good, if not better, 
for clinical prediction of mortality (Brannen, Godfrey, & Goetter, 1989; Kruse, Thill-
Baharozian, & Carlson, 1988; Scholz, et al., 2004).  However, in this time of constrained 
resources, a busy unit may lack an expert clinician; thus, a method to standardize 
assessment of a patient‘s unique risk is a complement to, not a replacement for the 
clinical judgment and decision making necessary for quality patient care. 
In addition, the overall feasibility and efficacy of a clinical prediction rule 
requires the sustained and coordinated ability to change the course of clinical outcomes. 
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For example, the knowledge of a high score on the Braden Scale for Pressure Sore Risk 
(Braden & Bergstrom, 1988) is clinically ineffective unless nursing interventions are 
implemented in conjunction with the score to avert the pressure ulcer.  Therefore, clinical 
prediction rules rarely stand alone.  Their ability to enhance the discrimination of an 
assessment requires the implementation of concurrent interventions or treatments (Morse, 
2006).  
Nursing implications.  In the continued quest to reduce HAI, clinical prediction 
rules are a potential strategy nurses could easily implement into the workflow to focus 
care, standardize assessments and guide nursing interventions.  Translating the risk of 
HAI into a quantifiable standardized score, via a clinical prediction rule, would provide a 
nurse-driven strategy to modify the environment for an individual patient‘s risk.  
Interventions such as cohorting of patients, determining optimal bed locations, allocation 
of private bed space, standing nursing orders for laboratory specimens or isolation, and 
coordinating increased staffing requirements are all nonpharmaceutical, nontechnological 
interventions that are well within a nursing scope of practice.  If applied on admission, a 
clinical prediction rule could identify those patients at highest risk for HAI and enable 
nurses to intervene on behalf of those patients deemed most vulnerable.    
Conceptual Framework 
The fundamental components of the epidemiologic triad of infection are the 
pathogen (agent), the exposure and the host defense (Nelson, K. E. & Williams, 2007).  
The interaction of these three components serves as the conceptual framework for 
modeling the transmission of infectious disease (Nelson, K. E. & Williams, 2007).  The 
pathogen component includes the virus, bacteria, parasite or fungi that are potentially 
  19 
infectious to the host.  The pathogen must be sufficiently virulent to gain access to the 
host in sufficient quantity and have the ability to replicate (Relman & Falkow, 2000).  
The ability of the pathogen to replicate and proliferate on or within the host distinguishes 
it from other pathogens that do not cause disease (Relman & Falkow, 2000).  The 
pathogen gains access to the host via exposure, the second component.  Exposure 
encompasses the environmental factors that modulate the amount and circumstances of 
how the agent gains entry into the host.  For example, environmental exposure may occur 
when health care providers practice poor hand hygiene or inadequate disinfection of 
medical equipment surfaces.  The exposure component includes all the ―extrinsic‖ factors 
relative to infection risk (Collins, 2008).  The third component, host defense, signifies the 
ability of the host to resist or fight the insult.  The host defenses comprise the ―intrinsic‖ 
factors of infection risk (Collins, 2008).  Infection ensues when a patient‘s host defenses 
lack the capacity to resist the exposure (Parsons & Krau, 2006) or when the host‘s normal 
defenses are lowered with treatments or drugs that render them more vulnerable to the 
invasion of a pathogen.  The ―chain of infection‖ puts into motion the series of 
physiological events that transpire when a pathogen successfully gains access to the host, 
replicates and the host response is overwhelmed, insufficient or blunted (Parsons & Krau, 
2006). 
The space created when these components intersect and overlap formulates the 
―risk‖ of infection prediction; the larger the area of intersection and overlap, the greater 
the likelihood a patient will develop an infection (risk). (See Figure 1.1)  Although expert 
clinicians can frequently identify patients at high risk for infection, rarely is an expert 
clinician available round-the-clock.  Furthermore, a patient that may be deemed at high 
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risk for HAI does not usually receive infection prevention interventions beyond standard 
protocol.  Whether or not any additional interventions (in terms of resources and 
manpower) would protect a vulnerable patient from an HAI infection is arguable.  
However, quantifying a patient‘s risk for infection upon initial assessment is undeniably a 
potential opportunity to reduce infection risk and a prospect that as of yet, remains 
unexplored for considerations in nursing care.   
Figure 1.1.  Conceptual Model of Infection Risk Prediction 
 
Translation of the intersection of the three components (pathogen, exposure and 
host) that comprise the ―risk‖ of CDI into a quantifiable score via a clinical prediction 
rule could be a mechanism to integrate a patient‘s initial assessment data into a useful 
tool for bedside clinical practice.  This is especially critical in combating the escalation of 
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HAI, where the traditional approach of reducing exposures appears insufficient and the 
modes of effective treatment are diminishing.  As depicted in Figure 1.2, a clinical 
prediction rule that includes the unique behavior of the pathogen, the specific 
characteristics of exposure and the vulnerabilities of the host, could be systematically 
translated into levels of low, medium and high risk infection scores.  A high score, 
indicating a high risk patient, would serve to drive interventions to modify the hospital 
environment in order to maximize individual patient outcomes early in, or prior to their 
hospitalization.  
Figure 1.2. Conceptual Model of Infection Risk Prediction Stratified by Risk Level. 
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Since the term risk is frequently used synonymously with the term vulnerable in 
the literature, a clarification of the two terms is necessary at this point. (Jacobs, 2000). 
The term risk infers that the probability or likelihood of the event occurring portends an 
adverse or dangerous outcome.  The term vulnerability is derived from the Latin word 
vulnerabilis, ―wounded or likely to injure‖ (Purdy, 2004, p. 83) and is defined in terms of 
individual characteristics (not group or population measures) that render a patient 
susceptible to, exposed to, or unprotected from infection (Purdy, 2004). In other words, 
whereas vulnerability addresses the underlying factors predisposing an individual to 
infection, risk addresses the immediate probability of acquiring an infection.  Therefore, 
in this context, a patient‘s individual vulnerability is regarded as a necessary condition of 
risk but not a sufficient component in and of itself to predict it; environmental and 
systems components may also contribute to risk.  The integration of both risk 
(intersection of circles) and vulnerability (within the host defenses) are captured in this 
framework and therefore provide a broad and comprehensive underpinning for the 
conceptual structure of a clinical prediction rule for HAI.  
In the next chapter, the focus of HAI is refined to one of the most serious 
offending organisms, C. difficile.  C. difficile recently surpassed MRSA as the most 
common nosocomial pathogen in hospitals within the United States (Dubberke, et al., 
2008) and therefore has both timely and practical significance as a chosen focus area for 
clinical prediction rule development. 
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Chapter II  
 
Background and Significance 
 
The Health care- Associated Infection of Clostridium difficile  
Clinical Presentation and Treatment.   
The clinical manifestations of CDI can range the full spectrum of infection from 
asymptomatic to life threatening (Giannasca & Warney, 2004; Pelleschi, 2008).  Mild 
forms of infections are characterized by frequent, nonbloody diarrhea and associated 
symptoms of fever, nausea, vomiting, and abdominal cramping which may progress to 
worsening symptoms of abdominal pain and colitis requiring aggressive medical 
management.  Fulminant disease develops in three to eight percent of CDI patients and is 
characterized by severe ileus megacolon, perforation, hypertension requiring vasopressor 
support or refractory septicemia (Jaber, Olafsson, Fung, & Reeves, 2008).   
Antimicrobial use almost always precedes CDI (McDonald, 2008).  Treatment 
with certain antibiotics is thought to suppress the normal host line of defense of 
indigenous colonic microflora and promote C. difficile pathogen proliferation.  Thus, the 
current first line treatment option has been discontinuation of putative offending 
antimicrobial agents (Kelly, 2009).  In some patients, and in the absence of all other 
antimicrobial treatment, discontinuation alone may cause the infection to subside (Kelly, 
2009; Nelson, R., 2007).  Depending on the severity of the illness, a CDI specific, 
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stratified antimicrobial treatment regime is now recommended (Kelly, 2009).  
Metronidizole is the first-line primary option for mild to moderate CDI (Cinti, Washer, & 
Chenoweth, 2007).  However, in patients with severe disease, vanocmycin has been 
associated with higher cure rates than standard metronidizole treatment (Nelson, R., 
2007).  Reliance on one of these two antibiotics remains one of the few effective weapons 
of choice against CDI (Kelly, 2009).  Further complicating the sufficiency of current 
treatment options is the rate of recurrence which has been reported to be as high as 20% 
(Aslam, Hamill, & Musher, 2005). 
In CDI refractory to conventional therapy, intravenous immunoglobin, higher 
doses of vancomycin, intracolonic administration of vancomycin and donor stool 
infusions are all documented treatments (Calfee, 2008).  When options for medical 
management are exhausted, an emergency surgical colectomy is considered an 
alternative, but risky, option (Jaber, et al., 2008).  Mortality associated with colectomy, 
although high, is reportedly better than sustained unsuccessful CDI medical management 
(Johnson, 2008; Lamontage, et al., 2007).  
Given the challenges of treating CDI, specifically recurrent CDI, alternative 
treatment measures to prevent the disease are being fully explored.  One potential 
preventive treatment measure against CDI that has received widespread attention is the 
use of probiotics (such as Lactobacillus casei, Streptococcus thermophilus, and 
Lactobacillus bulgars) (Hickson, et al., 2007).  Probiotics are hypothesized to enhance 
the normal intestinal microflora whereby they can effectively bolster the host‘s normal 
defenses against C. difficile colonization (Hickson, et al., 2007).  However, a recent 
comprehensive scientific review of the use of probiotics for the prevention of CDI 
  25 
concluded there was a dearth of strong evidence to recommend the clinical use of 
probiotic therapy for the prevention of CDI (Surawicz, 2008).   
Active immune response, via vaccination, is emerging as another alternative 
treatment for the prevention of CDI.  Passive protection from disease is acquired by a 
majority of patients when the body generates antibodies to toxin A after exposure to C. 
difficile (Louie, Peppe, Watt, & et al., 2006; Pelleschi, 2008). The inability of the body‘s 
ability to acquire the antibodies to toxin A has been associated with an increased severity 
of disease and relapse (Giannasca & Warney, 2004) suggesting an innate or acquired 
immune response may play a more important role than expected (Kuijper, Coignard, & 
Tull, 2006).  Theoretically, vaccination with inactivated and purified A & B toxins would 
provoke the stimulation of antibodies that would bind and dispose of the potent toxins 
responsible for CDI.  Although still at the preliminary stages of research, larger scale 
trials are necessary to establish vaccination as an effective alternative to antimicrobial 
therapy (Giannasca & Warney, 2004).   
Pathogen and Pathogenesis. 
The dramatic increase of the incidence of C. difficile and its transformation into a 
more dangerous pathogen is primarily associated with the hypervirulent strain identified 
as NAP1/BI/027 toxinotype III.  The complicated nomenclature was derived from the 
different typing systems used for identification of the C. difficile strain, namely, NAP1 
using pulsed-field gel electrophoresis (PFGE) pattern, BI using restriction endonuclease 
analysis (REA), toxinotype III by polymerase chain reaction (PCR) characterization of 
the pathogenicity locus, and 027 by PCR ribotyping (McDonald, et al., 2005).  Prior to 
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2000, the NAP1/B1/027 toxinotype III strain accounted for less than 1% of isolates of C 
difficile in the United States.  Now, however, the NAP1/B1/027 toxinotype III 
(designated NAP1 from this point forward) strain is the predominant strain in many 
hospitals across the nation and has been detected in over 10 European countries 
(McDonald, 2008).   
The pathogenicity of C. difficile is largely attributed to two potent toxins: toxin A 
(Tsd A) a 308-kDa enterotoxin, and toxin B (Tcd B) a 270-kDa cytotoxin (Kuijper, et al., 
2006).  Tsd A and Tsd B are both large single-chain proteins that are located on an area 
of the genome known as the pathogenicity locus  (PaLoc) (Kuijper, et al., 2006; Voth & 
Ballard, 2005).  Tsd A has long been considered the most important toxin to mediate 
diarrhea (Kuijper, et al., 2006), as it signals the release of inflammatory mediators which 
alter the cell wall junctions, increase cell permeability, and promote fluid secretion (Voth 
& Ballard, 2005).  The role of Tsd B is less understood, but is implicated in the disruption 
the epithelial integrity of cells in the colon (Voth & Ballard, 2005).  In the NAP1 isolate, 
Tsd A and Tsd B production is sixteen times and twenty-three times, respectively, greater 
than that of other C. difficile hospital-acquired strains (Warny, et al., 2005).  This 
production of increased toxin concentration has emerged as the primary explanation for 
the increased virulence of the NAP1 strain (Warny, et al., 2005).  
 Apart from Tsd A and Tsd B, two other factors may also be contributing to the 
increase in the virulence of C. difficile.  Recently, a newly discovered binary toxin (an 
actin-specific ADP-ribosyltransferase), has been suggested as an additional virulence 
marker for C. difficile.  Although the role of the binary toxin still remains largely 
unknown (Kuijper, et al., 2006), an increased prevalence of the binary toxin was isolated 
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from lethal outbreaks of CDI suggesting the binary toxin in the NAP1 strain may 
contribute to the severity of CDI (McDonald, et al., 2005).  Another distinguishing 
molecular characteristic of the NAP is an 18-base pair (bp) deletion in gene tcdC, a 
negative regulator of the production of Tsd A and Tsd B (McDonald, et al., 2005).  It is 
hypothesized that a tcdC gene mutation disrupts the normal regulatory feedback 
mechanism and promotes increased toxin production (McDonald, et al., 2005). 
 Based on virulence alone, it is unlikely that an uncommon strain of C. difficle 
could escalate to epidemic proportions (Blossom & McDonald, 2007).  Other variables, 
such as overuse of antibiotics and the emergence of antimicrobial resistance have been 
considered possible contributing factors in the dramatic rise of CDI.  Antibiotic treatment 
has long been considered a prerequisite for CDI since it disturbs the colonic microflora 
and allows the organism to proliferate in the lower intestine however, the emergence of 
the new antimicrobial resistance is attributed to the NAP1 strain.  The comparison of 
historical NAP1 isolates prior to 2001, with NAP1 isolates from recent outbreaks after 
2001, demonstrated a significant increase in the number of isolates resistant to 
fluoroquinolones (levofloxacin, gatifloxacin and moxifloxacin).  It appears the 
widespread use of antibiotics may have provided enough of a selective advantage for the 
NAP1 C. difficile strain to proliferate and further contribute to the emergence of CDI 
(McDonald, et al., 2005).    
Detection & Surveillance. 
A significant barrier to the detection, identification and surveillance of CDI at the 
hospital level is complicated by the lack of a sensitive and rapid diagnostic test for CDI 
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(Gerding, et al., 2008).  The most widely used diagnostic test is the enzyme-linked 
immunosorbant assay (EIA) test for toxin A or toxins A and B.  EIA‘s provide efficient 
testing turnaround in about 2 hours but they lack sensitivity (60-95%) (Blossom & 
McDonald, 2007), potentially underestimating the population with true disease.  Tissue 
cytotoxic assay is more specific but requires additional technical expertise and 48 hours 
for a definitive result (Blossom & McDonald, 2007).  The slow turnaround time prevents 
quick intervention to isolate, treat, and prevent person-to-person spread of the disease.  
While the traditional stool culture measures have fallen out of favor recently due to their 
inability to detect toxic from non-toxic producing strains (Blossom & McDonald, 2007), 
this has disabled a critical aspect of epidemiological surveillance, the ability to determine 
the offending strains (Blossom & McDonald, 2007).  Two and three step processes have 
been proposed to increase timeliness and preserve accuracy for the short-term and have 
recently been adopted at major U.S. centers, including the University of Michigan Health 
System (Dr. Laraine Washer, personal communication, February 19, 2009).  In the future, 
the availability of real-time PCR testing has the potential to provide the most accurate, 
rapid and sensitive testing option (Gerding, 2008).  
Community-Acquired vs. Hospital-Acquired CDI. 
 Although the incidence and severity of community-acquired CDI is rising in 
tandem with hospital-acquired CDI (McDonald, 2008), the strains and the risk factors 
that characterized a community-acquired CDI are markedly different.  In the community 
setting, antibiotic use has been found to be a predisposing factor in only half of the cases 
of CDI, which is in stark contrast to CDI in the hospital where antibiotic use is almost 
always precedent to CDI (McDonald, 2008).  Furthermore, the surveillance of C. difficile 
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strains in the community was heterogeneous with only16% of the strains identified as 
NAP 1 and a various array of toxinotypes.  It is worth mentioning that the rising, albeit 
different, presentation of community-acquired CDI versus the health care -acquired CDI, 
have shown a growth of toxinotype V, the primary toxinotype associated with C. difficile 
in calves and pigs (Jhung, et al., 2008; McDonald, 2008).  A possible animal-to-human 
transmission through retail meat in community-acquired CDI is an emerging hypothesis, 
but is yet unsubstantiated (Jhung, et al., 2008; McDonald, 2008).  
Exposure:  The Transmission of CDI in Hospitals. 
Exposure to C. difficile from inadequate personal hygiene, insufficient 
disinfection of surfaces and nonadherence to barrier precautions are considered important 
and significant contributors to the spread of the disease in the hospital environment 
(Boyce, 2007; Cohen, et al., 2010).  Since C. difficile can reside in a spore-form, where it 
is resistant to the bactericidal effects of alcohol and standard disinfectants unlike the 
common HAIs such as Staphylococcus aureus or Escherichia coli, alternative hygiene 
measures to reduce CDI are central to combating the spread of C. difficile contamination 
(Dubberke, et al., 2008).  Hand hygiene with alcohol-based hand sanitizers is ineffective 
against spores and therefore cannot be substituted for the traditional practice of hand 
hygiene with soap and water (Dubberke, et al., 2008).  Although the escalation in the 
rates of CDI has also been attributed to the progressive increase in the use of alcohol-
based hand sanitizers, evidence suggest the increased use of alcohol-based hand sanitizers 
to be unrelated (Boyce, Ligi, Kohan, Dumigan, & Havill, 2006a).   
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Several studies have reinforced the necessity for rigorous environmental 
decontamination of rooms of patients with CDI.  Similar to the ineffectiveness of alcohol-
based hand sanitizers, C. difficile spores can also resist the bactericidal effects of alcohol 
and most hospital disinfectants.  In an effort to eradicate C. difficile spores, some of 
which can persist on hard surfaces for prolonged periods (Gerding, et al., 2008), terminal 
cleaning of hospital rooms require the use of sodium hypochlorite (household bleach) 
diluted 1:10 (McMullen, et al., 2007).  Special attention must also be given to ―high 
touch‖ contaminated surfaces such as the nursing call light, bed side rails, intravenous 
pumps and bedside tables (Dubberke et al., 2008)  
The importance of the environmental exposure is underscored by a recent 
investigation demonstrating that the risk of CDI increased with the number of patients 
with CDI on a unit or ward, termed the ―Clostridium difficile-associated disease pressure‖ 
or CDAD pressure (Dubberke, et al., 2007b).  In fact, the investigators found C. difficile 
colonization pressure to be one of the strongest independent risk factors for CDI 
(Dubberke, et al., 2007b).  The ability to predict an increased risk of CDI when 
hospitalized patients are in close proximity to CDI patients is an important implication 
for the prevention and control of endemic CDI (Dubberke, et al., 2007b; McDonald, 
2008).  Similarly, the risk of CDI was increased when a patient was assigned to a room 
where a prior occupant had been diagnosed with CDI or adjacent to it (Howitt, et al., 
2008; Shaughnessy, et al., 2011).  Even after controlling for established CDI risk factors 
(severity of illness, exposure to PPI and antibiotic use), the acquisition of CDI infection 
was significantly associated (p=.002) with a higher rate of CDI infection (Shaughnessy, 
et al., 2011).   
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Another recent study demonstrated a greater risk of CDI when the exposure 
factors of a previous recent hospitalization or a transfer from another hospital were 
present (Kyne, et al., 2002; Southern, et al., 2010).  Similarly, a higher risk of CDI was 
also associated with a greater length of stay (LOS) and hospitalization in a medical center 
(versus community hospital) (Bliss, et al., 1998; Garey, et al., 2008; Zerey, et al., 2007).  
These findings clearly suggest that the environmental exposure to C. difficile has 
contributed to the rise in the incidence of CDI and therefore, interventions to reduce CDI 
must encompass a broad range of early, proactive and comprehensive environmental 
control strategies. See Table 2.1 for a synopsis of the CDI risk factors related to the 
conceptual construct of Exposure.  See Appendix A for a summary of the research studies 
cited for this evidence.   
Table 2.1  
 




Type of hospital (medical center, community) (Zerey, et al., 2007) 
Hospital room assignment (Howitt, et al., 2008; Shaughnessy, et al., 
2011) 
Recent hospitalization/ Prior Operation/ER visits (Kyne, et al., 2002; Oake, et al., 2010; 
Southern, et al., 2010) 
Length of stay (Bliss, et al., 1998; Garey, et al., 2008; 
Zerey, et al., 2007) 
Transfer –in from another facility (Kyne, et al., 2002) 
C. difficile colonization pressure (Dubberke, et al., 2007a; Dubberke, et al., 
2007b) 
Insufficient disinfection of surfaces (McMullen, et al., 2007) 
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Host Defense in CDI:  Patient Characteristics and Treatment-Related Variables.  
Not all patients that are exposed to C. difficile develop CDI (Kelly, 2009).  Why 
some patients can escape C. difficile exposure unscathed, while for others it is lethal, 
underscores the complex pathogenesis of CDI and the importance of the host health and 
immune status.  The variables affecting host resilience to CDI can be separated into two 
main categories: (1) patient characteristics, and (2) treatment-related variables that render 
the host more vulnerable to colonization.  
Patient characteristics.  The two classic patient characteristics associated with an 
increased risk of CDI are age and severity of illness.  The increased risk of CDI and 
advanced age has been demonstrated repeatedly (Crabtree, et al., 2007; Dubberke, et al., 
2007b; Garey, et al., 2008; Kyne, et al., 2002; Metzger, et al., 2010; Rodrigues, Brady, 
Rodrigues, Graham, & Gibb, 2010; Zerey, et al., 2007) and recently confirmed in subsets 
of surgical patients (Crabtree, et al., 2007; Zerey, et al., 2007).  The association between 
CDI and advanced age has been attributed to a declining humoral and innate immune 
response although there is little evidence to suggest that older patients have a less 
developed immune response to the C. difficile toxins than their younger counterparts 
(Pepin, et al., 2005).   
Severity of illness has been identified as a risk factor for CDI in several studies, 
although different measures of illness severity were described (Dubberke, et al., 2007b; 
Kyne, et al., 2002; Metzger, et al., 2010; Peled, et al., 2007; Pepin, et al., 2005; Vesta, 
Wells, Gentry, & Stipek, 2005) and often, severity of illness was used as a surrogate to 
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predict patient mortality (Ang, Heyes, Morrison, & Carr, 2008; Bhangu, et al., 2010; 
Velazquez-Gomez, et al., 2008) rather than as predictive factor for disease.  As one 
would expect, the risk factors of age and severity of illness were found to be frequently 
related to each other and therefore have been confounding variables in the investigation 
of CDI (Pepin, et al., 2005). 
Because the epidemiology of C. difficile has recently changed into a more virulent 
and deadly pathogen, there is only limited evidence to fully understand the how age and 
severity of illness contribute to CDI risk.  However, more sensitive factors of host 
vulnerability have started to emerge in recent research investigations.  For example, CDI 
has been associated with diabetes (Rodrigues, et al., 2010) cardiovascular disease 
(Lesperance, Causey, Spencer, & Steele, 2011; Rodrigues, et al., 2010), cancer  
(Dubberke, et al., 2007b; Rodrigues, et al., 2010) pulmonary disease (Dubberke,, et al., 
2007b; Rodrigues, et al., 2010), obesity (Lesperance, et al., 2011) malnutrition 
(Lesperance, et al., 2011) , anemia (Rodrigues, et al., 2010), and renal disease (Eddi, et 
al., 2010; Garey, et al., 2008; Kyne, et al., 2002).  Specific markers for underlying risk 
included leukocytosis and hypoalbuminemia (Dubberke, et al., 2007b; Peled, et al., 
2007).  Functional status, a measure of a patient‘s independence in daily activities, was 
also identified as a risk factor for CDI (Peled, et al., 2007) and implicated as a risk factor 
in recurrent (not primary, CDI) because of its association with stroke (Cadena, et al., 
2010).  As these recent studies suggest, identifying and understanding the intrinsic factors 
of the host may be particularly important in preventing CDI especially in vulnerable 
patient populations.   
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Although the variables of race and gender are routinely analyzed in research 
studies, neither has been associated with CDI.  Only two studies have demonstrated either 
race or gender as significant risk factors for CDI after multivariate analysis (Crabtree, et 
al., 2007; Lesperance, et al., 2011).  Lesperance et al, (2011) identified race as a 
statistically significant risk factor for CDI when compared with their nondiseased 
controls but race was analyzed as a dichotomous variable (Caucasian vs. non-Caucasian) 
which may have decreased the variability in the sample population.  Similarly, the risk of 
the female gender, identified as a risk factor in a study by Crabtree et al (2007) lacked 
collaboration in other surgical cohorts (Metzger, et al., 2010; Southern, et al., 2010).  
Therefore, whether or not race or gender significantly contribute to a patient‘s risk of 
CDI is unclear and requires additional inquiry.  See Table 2.2 for a synopsis of the CDI 
risk factors related to the conceptual construct of Host vulnerability.  See Appendix A for 
a summary of the research studies cited for this evidence.   
Table 2.2  
 
Summary of CDI Risk Factors Associated With Host Vulnerability 




(Crabtree, et al., 2007; Dubberke, et al., 2007b; 
Garey, et al., 2008; Kyne, et al., 2002; Metzger, et al., 
2010; Rodrigues, et al., 2010; Zerey, et al., 2007) 
 
Female sex (Crabtree, et al., 2007) 
 
Race (Lesperance, et al., 2011) 
 
Severity of Illness 
 
Horn‘s Index (Kyne, et al., 2002; Peled, et al., 2007; 
Vesta, et al., 2005) 
APACHE (Dubberke, et al., 2007b; Metzger, et al., 
2010) 
Charlston Comorbidity Index (Pepin, et al., 2005) 
  
Diabetes (Rodrigues, et al., 2010) 
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Cardiovascular disease (Lesperance, et al., 2011; Rodrigues, et al., 2010) 
 
Cancer (Dubberke, et al., 2007b; Rodrigues, et al., 2010) 
 
Pulmonary disease (Dubberke, et al., 2007b; Rodrigues, et al., 2010) 
 
Obesity (Lesperance, et al., 2011) 
 
Malnutrition (Lesperance, et al., 2011) 
 
Anemia (Rodrigues, et al., 2010) 
 
Renal disease (Eddi, et al., 2010; Garey, et al., 2008; Kyne, et al., 
2002) 
 
Leukocytosis (Dubberke,  et al., 2007b; Peled, et al., 2007) 
 
Hypoalbuminemia (Dubberke, et al., 2007b; Peled, et al., 2007) 
 
Functional Status (Peled, et al., 2007) 
 
 
Treatment-related variables.  Treatment-related variables associated with 
increasing the risk of CDI include the use of antimicrobial therapy (Aslam & Musher, 
2006; Davey, et al., 2009; Owens, et al., 2008), gastric acid suppression (proton pump 
inhibitors and H2-receptor antagonists) (Dial, Alrasadi, Manoukian, Huang, & Menzies, 
2004; Dubberke, et al., 2007b; Peled, et al., 2007), tube feeding (Bliss, et al., 1998) blood 
product transfusions (Crabtree, et al., 2007) and gastrointestinal surgery (Howitt, et al., 
2008; Rodrigues, et al., 2010; Zerey, et al., 2007).  Specific to surgical patients, the use of 
mechanical bowel preparation (with antibiotics) has also been implicated in CDI risk 
(Wren, Ahmed, Jamal, & Safadi, 2005). 
As discussed previously, the treatment-related variable that poses the greatest risk 
for CDI is antimicrobial therapy (Calfee, 2008; Davey, et al., 2009; McDonald, et al., 
2005; Owens, et al., 2008).  While all classes of antimicrobial therapy have been 
implicated in CDI, clindamycin, third-generation cephalosporins and pencillins are 
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considered the greatest offenders (Owens, et al., 2008).  Recently, the use of 
fluoroquinolones has also been identified as a risk factor for CDI, however, this finding 
was attributed to antimicrobial resistance among the NAP1 strain (McDonald, et al., 
2005).  In addition to the type of antibiotic, emerging evidence has also implicated the 
duration of antimicrobial use and the concomitant use of multiple antimicrobials to 
confound the risk for developing CDI (Owens, et al., 2008).  Thus, the implementation of 
antimicrobial stewardship programs, in concert with environmental control strategies, are 
regarded as critical for the reduction of  CDI (Davey, et al., 2009; Dubberke, et al., 2008; 
Fowler, et al., 2007; Gerding, et al., 2008). 
There is a recent and accumulating body of research associating an increased risk 
of CDI with the use of gastric ulcer suppressors, specifically, a proton pump inhibitor 
(PPI) (Cunningham & Dial, 2008; Dubberke, et al., 2008).  This association seems 
plausible considering PPIs reduce gastric acid secretion and therefore hinder the key 
defense mechanism the host has to fight against intestinal infection.  Although several 
convincing studies suggests an association between PPI and CDI in hospitalized patients 
(Aseeri, Schroeder, Kramer, & Zackula, 2008; Cadle, Mansouri, Logan, Kudva, & 
Musher, 2007; Dial, et al., 2004; Peled, et al., 2007), there is also evidence to the contrary 
(Beaulieu, Williamson, Pichette, & Lachaine, 2007; Lowe, Mamdani, Kopp, Low, & 
Juurlink, 2006; Pepin, et al., 2005).  Additional evidence is required to elucidate the role 
of proton pump inhibitors in CDI, divorced from the impact of the confounding variables 
such as age and severity of illness, before the causation of CDI from PPIs can be 
determined.  
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Three important risk factors for CDI that are commonplace in routine nursing care 
are the manipulation and delivery of tube feedings and patient bathing.  The use of tube 
feedings has been independently associated with a higher rate of CDI (Bliss, et al., 1998) 
but the evidence is limited and the etiology remains unclear.  The higher rate of CDI has 
been attributed to the contamination of the tube feeding apparatus during routine care or 
even the lack of fiber in the nutritional supplement (Bliss, et al., 1998).  Bed baths, part of 
the daily routine of a hospitalized patient, decreases the colonization of pathogens on a 
patient‘s skin.  However, in CDI, the concentration may be more efficient and improved 
when the patient is given the opportunity to shower.  Much like the physical act of hand 
washing, the effectiveness of the cleansing action of the shower water has been found to 
decrease the burden of spores on the skin of patients with CDI (Jury, Guerrero, Burant, 
Cadnum, & Donskey, 2011).  This may be especially useful for patients with fecal 
incontinence since stool releases a heavy burden of spores into the hospital environment.  
Among surgical patients, those who undergo colectomy are at the highest risk for 
CDI (Howitt, et al., 2008; Rodrigues, et al., 2010; Zerey, et al., 2007).  This is primarily 
attributed to the additional physical disruption of the indigenous colonic microflora 
(Zerey, et al., 2007).  Traditionally, bowel preparation with oral antibiotic prophylaxis 
has been the standard of care for colon and rectal surgery (Zmora, et al., 2003) because it 
rids the intestines of bulk stool and reduces the residual live bacteria during the surgical 
procedure.  Recently, this common practice has been implicated as a possible antecedent 
to CDI because of the eradication of the normally protective microflora (Wren, et al., 
2005).   
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Wren et al. (2005) concluded the addition of oral antibiotics to mechanical bowel 
preparation significantly increased the rate of CDI.  Although limited by a retrospective 
case-controlled design, there is little other available research comparing the impact of 
bowel preparation regimens and the risk of CDI.  Therefore, the use of bowel preparation, 
both with and without antibiotics, has become a topic of debate among traditionalists who 
cite prolonged experience and success of the practice and empiricists who cite adverse 
outcomes per randomized trial evidence (Espin-Basany, et al., 2005; Lewis, 2002; Slim, 
Vicaut, Launay-Savary, Contant, & Chipponi, 2009).  Whether or not bowel preparation 
contributes to the risk of CDI has timely importance for patients undergoing colectomy 
surgery since the rate and virulence of CDI continues to climb in this population (Zerey, 
et al., 2007).   
Also unique to the surgical patient population is the association of CDI and blood 
product transfusions.  Although the evidence is limited (Crabtree, et al., 2007), the use of 
blood transfusions has been implicated in other HAI‘s (Campbell, et al., 2008).  
Additional investigations may help to clarify whether or not the use of blood transfusions 
are a unique risk factor in CDI or a surrogate for other factors such as severity of illness 
or immunosuppression.  See Table 2.3 for a synopsis of the CDI risk factors related to the 
conceptual construct of host factors that were Treatment-related.  See Appendix A for a 
summary of the research studies cited for this evidence.   
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Table 2.3 
  




Antibiotics (Davey, et al., 2009) 
Gastric acid suppression (Dubberke, et al., 2007b; Peled, et al., 2007) 
Tube feeding (Bliss, et al., 1998) 
Blood product transfusions (Crabtree, et al., 2007) 
Gastrointestinal surgery (Howitt, et al., 2008; Rodrigues, et al., 2010; 
Zerey, et al., 2007) 
Mechanical bowel preparation with antibiotics (Wren, et al., 2005) 
 
Summary 
Now the most common HAI (McDonald, et al., 2006), the incidence of CDI is 
rising dramatically while the treatment options are narrowing.  The problem may be due, 
at least in part to a hypervirulent strain of C. difficile which is more severe and deadly 
(McDonald, et al., 2005).  Compounding the problem is the disproportionate burden of 
infection CDI has on the elderly (McDonald, et al., 2006).  Effective efforts to curb the 
escalation of CDI are focused on decreasing the exposure of the organism by enhanced 
personal hygiene, improved disinfection of surfaces and adherence to barrier precautions.  
Parallel efforts are also underway to maximize the host resistance by reducing treatment-
related modulators such as antimicrobial stewardship programs (Dubberke, et al., 2008).   
Despite efforts to mitigate the epidemic of this virulent infection, the rate of CDI 
continues to escalate without evidence of a peak or plateau (Gerding, 2008).  
Identification of risk factors that predispose a patient to CDI will be critical in providing 
clues as to where preventive interventions should be targeted and how resources should 
be expended.  Because the epidemiological changes in C. difficile are of a relatively new 
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science, there is limited high-quality evidence per randomized trials to support unilateral 
changes in practice.  However, evidence is beginning to accumulate which can help 
clinicians to better understand the host, exposure, and treatment-related variables that 
contribute to the risk of CDI.    
Knowledge of these risk factors is especially important for vulnerable patient 
populations or locations in the hospital that that have unacceptably high rates of CDI.  In 
these instances, a clinical prediction rule for quantifying the risk of infection would 
enable healthcare providers to anticipate infection, and not simply react to its sequela.  
Valid and reliable screening tools to identify patients for infection risk are not standard 
procedures in most hospitals and even though risk screening for infection using 
computer-assisted predictors has been discussed in the literature, its purpose has been 
primarily surveillance and administrative rather than an assessment tool at the bedside.  A 
clinical prediction rule, applied by nurses, early in, or prior to, hospitalization is a 
strategy to protect vulnerable patients, target preventative interventions, improve 
outcomes for CDI, and a method to translate evidence into clinical practice 
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Epidemiologic data suggest that the burden of CDI is increasing among surgical 
patients, especially among patients having intestinal tract resections or colectomies 
(Zerey, et al., 2007).  Colectomy patients are almost twice as likely to acquire CDI as 
patients having other surgical procedures (Zerey, et al., 2007).  This investigation seeks 
to identify the unique risk factors predictive of CDI in a cohort of non-emergent 
colectomy surgical patients using data collected as part of the Michigan Surgical Quality 
Collaborative (MSQC).  Results of this study are intended to serve as a beginning step, in 
a series of studies, in the development of a clinical prediction rule for CDI in this 
vulnerable patient population.  A clinical prediction rule specific for initial onset of CDI 
in surgical patients is without precedence in the published literature and has received only 
limited attention in other patient populations (Hu, et al., 2008; Kyne, et al., 2002). 
Aims 
The aims of this study were to: 
1)  Determine the significant univariate associations between the preoperative risk factors 
of patients with CDI and without CDI.  
2)  Integrate the most robust variables associated with CDI in the postoperative 
colectomy patient into a clinical prediction rule model. 
3)  Evaluate the predictive accuracy of the CDI prediction rule. 
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Research Design and Methods 
 Using a retrospective, cohort design, this research examined the predictive 
variables associated with CDI and constructed a model to determine a prognostic 
estimation of risk based on statistical derivation (Aim One and Aim Two).  Evaluation of 
the model (Aim Three) evaluated the predictive rule‘s external validity and clinical 
impact.  Institutional Review Board approval was obtained from the University of 
Michigan Institutional Review Board-Medical (HUM00033887). 
Setting 
 The data collected as part of MSQC Project comprised the cohort population for 
this investigation.  The MSQC, headquartered in Ann Arbor, Michigan, is an organization 
commissioned to measure and improve the quality of care through regional collaboration.  
A coalition of 24 teaching and community hospitals across the state of Michigan are 
currently enrolled in the MSQC which is funded, in part, by Blue Cross Blue Shield of 
Michigan and the Blue Care Network (Michigan Quality Surgical Collaborative, 2009).  
The Colectomy Project, a special subset of the larger MSQC initiative, was started in 
2007 to better understand best practices in various areas of colon surgery, a high-volume, 
high-risk procedure.  This unique initiative, augmenting the American College of 
Surgeons National Surgical Quality Improvement Program (ACS NSQIP), collects 
perioperative patient characteristics, intraoperative processes of care and postoperative 
outcomes from general and vascular surgery patients.  Dr. Darrel A. Campbell, Jr. MD, a 
pioneer of the MSQC initiatives, is the Program Director of the MSQC, and one of the 
principle forces behind the development and implementation of the ACS NSQIP in non-
VA hospitals (Campbell, et al., 2008; Fink, et al., 2002). 
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Sample   
 All adult patients (18 years and older) enrolled into the MSQC Colectomy Project 
between August 15, 2007 and June 30, 2009 were eligible for the extant study.  Because 
there is a great deal of variation in the different types of operations performed on the 
colon, MSQC data collection was targeted to a very specific subset of Current Procedural 
Terminology Modification (CPT) codes, referred to as the colon ―bucket‖ (Michigan 
Quality Surgical Collaborative, 2009)  (See Table 3.1. ). 
Table 3.1  
 
The Four CPT Codes included for the MSQC Colectomy Project 
CPT Code 
 














Laparoscopic colectomy, partial with anastomosis 
44205 
 
Laparoscopic colectomy with removal of terminal ileum with 
ileocolstomy  
  
 By January 2010, an estimated 1800 total nonemergent colectomy patients had 
been accrued into the Colectomy Project, Fifty-four of those patients (three percent) are 
anticipated to be diagnosed with CDI postoperatively.   Three percent falls on the lower 
end of the range of between two and seven percent given in the current literature (Wren, 
et al., 2005).  This is likely due to the strict definition of CDI (including only diagnostic 
validation of C. difficile) and the restriction of the sample to only those patients 
undergoing emergent (versus nonemergent) colectomy procedures.  The sample was 
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restricted to only nonemergent colectomy procedures in order to narrow the 
compounding preoperative variables associated with emergent colectomy such as 
immunosuppression and disease severity (Yoo, Mulkeen, Frattini, Longo, & Cha, 2006).   
Power analysis was conducted using NQuery software to determine the adequacy 
of the sample size to provide 80% power for the logistic regression analyses used to meet 
Aim Two with alpha of .05, two-tailed.  For Aim two, seven predictors were to be used to 
predict CDI in logistic regression. A medium size effect was sought, i.e., an odds ratio of 
2.0 in logistic regression (Cohen, J., 1988).  NQuery software indicated that a sample size 
of 552 would provide 80% power for logistic regression assuming a squared multiple 
correlation of the key predictor with other predictors was 0.2 and an overall rate of 
infection of 2%.  This sample size is less than the estimated available sample size of 1800 
so power will be over 80% for analysis of Aim Two.  The power analysis focuses on Aim 
Two as this aim addresses the test of the full (multivariate) prediction model. 
Data Source 
The ACS NSQIP is a national outcome-based, risk-adjusted, peer-controlled 
program for the reporting and measuring of quality surgical care and patient outcomes 
(Khuri, 2005).  The proprietary program currently includes 234 hospitals across the 
United States (American College of Surgeons National Surgical Quality Improvement 
Program, 2009).  At each participating hospital, a specially trained, dedicated surgical 
clinical reviewer, prospectively collects preoperative, intraoperative, and 30-day surgical 
outcome data for major surgical operations.  The clearly defined and standardized data 
collection methodology is routinely validated through scheduled site visits, conference 
calls and meetings.  All eligible surgical operations are included at lower volume 
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hospitals.  However, in order to reduce sampling error, only the first 36 cases of an 8 day 
cycle (alternating different days of the week each cycle) are collected for high volume 
institutions (Khuri, 2005). 
 The data abstracted for this study included both the ACS NSQIP and MSQC data.  
The ACS NSQIP contains over 135 variables for each surgical patient (ACS 
NSQIP,2010) and the MSQC Colectomy Project data, which is collected by the same 
surgical clinical reviewer, contains an additional data field that incorporates 25 specific 
elements of interest to colorectal surgeons and the outcomes of the colectomy patient 
(See Appendix B).  The MSQC Colectomy Project data fields are not designed to stand 
alone; ACS NSQIP data is collected in conjunction with the MSQC Colectomy Project 
under the same patient identifier.    
 The MSQC dataset will provide the treatment-related variables of mechanical 
bowel prep, mechanical bowel prep with antibiotics and the outcome variable of CDI.  
All other variables will be ascertained as part of the larger ACS NSQIP data elements.  
Measures  
Dependent Variable.  The presence of infection with the C. difficile organism 
was the outcome measure.  In order to be considered a CDI, the presence of C. difficile 
had to be verified by laboratory detection of the toxin in the stool or by a positive stool 
culture.  Empirical treatment alone was insufficient to verify infection.  See Appendix C 
for MSQC operational definition. 
Independent Variables.  The risk predictive factors were theoretically derived 
from the literature review and classified via the three foundational components of the 
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epidemiological triad of the infection conceptual model.  The risk factors were then 
matched to variables included within both the ACS NSQID and MSQC data elements.  
They are summarized below within each construct of the model, Host, Treatment-related 
and Exposure.  
 Host.   
As summarized in Table 3.2, a total of seven patient characteristics, twenty 
preoperative cormorbid conditions and two laboratory variables were selected for 
analysis.   Two variables were used as a proxy for risk factors that were not available in 
the database :  (1) American Society of Anesthesiologists (ASA) Physical Status 
classification as a proxy for severity of illness and (2) the hematocrit level as a proxy for 
anemia.  The American Society of Anesthesiologists (ASA) Physical Status classification 
is a measure of a patients physical status prior to surgery (American Society of 
Anestheologists, 2011).  It was developed in 1941 as a measure to classify and grade 
patients in relation to their physical status prior to surgery (Lema, 2002).  Since then, the 
ASA classification system has been used, mostly by disciplines outside of anesthesia, as a 
measure to classify patients into severity levels and estimate their risk of morbidity and 
mortality (Davenport, Bowe, Henderson, Khuri, & Mentzer, 2006; Lema, 2002).  As an 
indicator of anemia, the hematocrit level was used as a proxy.  The hematocrit level is a 
test of the level of red blood cells and is a routine screening for anemia (Guyton & Hall, 
2006). 
In order to capture the most relevant patient information, one variable was 
constructed from the original data elements and two others reduced from categorical 
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measures to dichotomous outcomes.  The constructed variable, body mass index (BMI), 
was calculated taking the data elements of height and weight.  The data element for 
functional status was reduced from a categorical variable (independent, partially 
dependent and totally dependent) to a dichotomous variable (independent/ non-
independent) since less than three patients populated the total dependent category.  The 
data element for dsypnea was collapsed to a dichotomous variable (none/moderate 
exertion and at rest) for the same reasons. 
Table 3.2  
 
Independent Variables for Host   
Independent Variable In Data Set? Type Definition † 
Patient Characteristics 
1. Age YES Continuous Chronological age 
2. BMI YES Continuous Calculated  by dividing the body weight by the 
square of the height 
3. Gender YES Dichotomous Male or Female 
4. Race and  
    Ethnicity 
YES Categorical  
Dichotomous 
Race as reported by patient (White, Black or 
African American, American Indian, Native 
Hawaiian or Pacific Islander, Asian).  






Smoked cigarettes in the year prior to surgery 
 6. ASA Physical Status 
Classification  
(proxy for severity of illness) 
  
YES Categorical ASA 1 -Normal healthy patient  
ASA 2 -Patient with mild systemic disease  
ASA 3 -Patient with severe systemic disease  
ASA 4 -Patient with severe systemic disease 
that is a constant threat to life 
 ASA 5 -Moribund patient who is not 
expected to survive without the operation. 
ASA 6 not in dataset 
7. Functional status 
 - prior to surgery  
 - prior to current illness 
YES Dichotomous Level of self-care for activities of daily 
living demonstrated by the patient prior to 
surgery and prior to current illness.   
Independent:  The patient does not 
require assistance from another person for 
any activities of daily living.     
Partially dependent or totally 
dependent:  The patient requires some 
assistance or total assistance from another 
person for activities of daily living  
Comorbidities 
Pulmonary 
1.  Dyspnea YES Dichotomous Difficult, painful, or labored breathing. 
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2.  Ventilator dependent YES Dichotomous Requiring ventilator-assisted respiration at any 
time during the 48 hours preceding surgery. 
3.  COPD YES Dichotomous History of COPD such as emphysema and 
chronic bronchitis. 
Cardiovascular 
4. History of CHF YES Dichotomous History of CHF within the previous 30 days.   
5.  MI (within 6 months) YES Dichotomous History of Q wave or a Q wave myocardial 
infarct in the six months. 
6.  Cardiac surgery (previous) YES Dichotomous Any major cardiac surgical procedure 
(performed either as an ‗off-pump‘ repair or 
utilizing cardiopulmonary bypass).   
7.  Angina YES Dichotomous Chest pain or discomfort within one month 
prior to surgery. 
8.  Hypertension YES Dichotomous Systolic blood pressure > 140 mmHg or a 
diastolic blood pressure > 90 mmHg or 
requires an antihypertensive treatment. 
Central Nervous System 
9.  Impaired sensorium YES Dichotomous Acutely confused and/or delirious but responds 
to verbal and/or mild tactile stimulation within 
48 hours prior to surgery 
10.  CVA with neurological deficit) YES Dichotomous History of a cerebrovascular accident (embolic, 
thrombotic, or hemorrhagic) with persistent 
residual motor, sensory, or cognitive 
dysfunction 
11.  CVA (without neurological 
deficit) 
YES Dichotomous History of a cerebrovascular accident (embolic, 
thrombotic, or hemorrhagic) with neurologic 
deficit(s) lasting at least 30 minutes, but no 
current residual neurologic dysfunction or 
deficit. 
12.  Hemiplegia YES Dichotomous Sustained acute or chronic neuromuscular 
injury resulting in total or partial paralysis or 
paresis (weakness) of one side of the body (not 
a single limb). 
13.  TIA YES Dichotomous Reports focal neurologic deficits of sudden 
onset and brief duration (usually <30 minutes) 
that usually reflects dysfunction in a cerebral 
vascular distribution.  
Renal 
14.  Acute renal failure YES Dichotomous The clinical condition associated with increase 
in BUN level and creatinine of above 3 mg/dl. 
15.  Dialysis YES Dichotomous Acute or chronic renal failure requiring 
treatment with peritoneal dialysis, 
hemodialysis, hemofiltration, 
hemodiafiltration, or ultrafiltration 
within 2 weeks prior to surgery. 
Other 
16. Diabetes YES Dichotomous Requires daily dosages of exogenous 
parenteral  insulin or an oral hypoglycemic 
agent to prevent a hyperglycemia/metabolic 
acidosis. 
17. Disseminated Cancer YES Dichotomous Cancer that has spread to one site or more sites 
or who has multiple metastases. 
18.  Chemotherapy YES Dichotomous Chemotherapy treatment for cancer in the 30 
days prior to surgery. 
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19.  Radiotherapy YES Dichotomous Radiotherapy treatment for cancer in the 90 
days prior to surgery. 
20. Weight loss >10%‖ YES Dichotomous Greater than 10% decrease in body weight in 
the six month interval immediately preceding 
surgery. 
Laboratory 
21.WBC count YES Continuous Pre-operative WBC 
22. Hematocrit (proxy for anemia) YES Continuous Pre-operative hematocrit 
† Definitions are abbreviated from the ACS NSQIP variable data element descriptions (American College of Surgeons National Surgical Quality Improvement Program, 2010). 
BMI = Body Mass Index;  ASA= American Society of Anesthesiologists  COPD= Chronic Obstructive Pulmonary Disease  CHF= Congestive Heart Failure; MI =Myocardial 
infarction; CVA =cerebrovascular accident; TIA =transient ischemic attack; WBC =White blood cells; BUN= Blood urea nitrogen. 
Treatment-related. 
Since patients undergoing colectomy comprise the cohort of the population, this 
risk factor was already included within the cohort, however, the CPT codes for whether 
or not the patient received a laparoscopic or open procedure were retained for analysis 
since laparoscopic surgery has been associated with lower morbidity (Masoomi, et al., 
2011). Unfortunately, variables of whether or not patients received acid suppression 
medications, preoperative antibiotics and whether or not the patient was being tube fed, 
were not available in the data set and a sufficient proxy was unavailable.  (See Table 3.3) 
Table 3.3   
 
Independent Variables Treatment-related 




1. Blood Transfusions YES Dichotomous Greater than 4 units of whole 
blood/packed red cells transfused 
during the 72 hours prior to surgery.† 




Included patients that received :** 
- Magnesium citrate 
- Fleet Phospho-soda 
- Fleet enema(s) 
- Polyethylene glycol (PEG),   
electrolyte solutions 
(GoLYTELY, etc), 
- Other, specified prep 
- Other, unknown type 
- Information unavailable 
3. Mechanical Bowel Prep 
with Antibiotics  
YES Dichotomous Evidence of oral antibiotics with 
bowel preparation in medical 
record.** 
4. CPT codes YES Categorical  The CPT code of the principal 
operative procedure: 
44140 - Open colectomy, partial with 
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anastomosis 
44160 - Open colectomy, partial with 
removal of terminal ileum with 
ileocolostomy 
44204-  Laparoscopic colectomy, 
partial with anastomosis 
44205 - Laparoscopic colectomy with 
removal of terminal ileum with 
ileocolstomy 
 
† Definition is abbreviated from the ACS NSQIP variable data element descriptions  
(American College of Surgeons National Surgical Quality Improvement Program, 2010);  
**Full operational definitions for MSQC data elements are in Appendix C;  
CPT code= Current Procedural Terminology Modification code 
Exposure. 
With the intent to protect the privacy of the participating hospitals, no variable 
was included in the data set that identified individual hospitals so the hospital-level 
variables of type, room assignment and C. difficile colonization pressure were not 
available to measure.  Two important risk factors for CDI, prior operations and transfer 
from another facility could both be measured with data elements in the data set.  Length 
of stay is an important risk factor for CDI postoperatively, however, only preoperative 
variables constructed the conceptual underpinnings of this study.  Therefore, the variable 
of days from hospital admission to operation was used to measure a patients exposure to 
C. difficile while in the hospital prior to surgery. (See Table 3.4) 
Table 3.4  
 
 Independent Variables for Exposure 




1. Prior Operation (30 days) YES Dichotomous Major surgical procedure performed within 30 
days prior to the assessed operation. 
2. Days from Hospital Admission to 
Operation (Preoperative length of 
stay).  
 
YES Continuous Days from Hospital Admission to Operation. 
3. Transfer from health care 
facility 
YES Categorical  Transfer status includes: 
-  Admitted from home 
-  Acute care hospital 
-  Chronic care facility 
-  Other  
† Definitions are abbreviated from the ACS NSQIP variable data element descriptions (American College of Surgeons National Surgical Quality Improvement Program, 2010). 
  
  51 
Figure 3.1 is a summary of all the independent variables within the conceptual 
model components of Host, Treatment-related and Exposure.   
Figure 3.1. Conceptual Model of Clostridium difficile Infection Risk with Independent Variables 
         
Abbreviations: BMI= body mass index; ASA= The American Society of Anesthesiology ; LOS=length of stay; ER= emergency room; CPT code= Current Procedural 
Terminology Modification code 
Analysis 
Specific Aim 1:  Determine the preoperative risk factors of colectomy patients 
diagnosed with CDI as compared with colectomy patients without CDI.  
This aim serves as the foundation for prediction rule model development.  
Univariate associations between independent variables and incidence of CDI were 
estimated using χ 2 (chi-square test) and two-sample t-tests. The majority of preoperative 
variables, therapeutic variables, and exposure variables were coded as dichotomous or 
categorical variables, and χ 2 was used to estimate associations with the outcome, CDI.  
The Fisher‘s exact test was done in those instances where the cell numbers were ≤  five 
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(IBM SPSS Statistics, 2011).  A two-sample t-test was used to estimate association 
between age, BMI, laboratory values and preoperative length of stay as these variables 
are continuous measures.   
Any variable with a p-value ≤  to 0.15 in the univariate analysis was considered as 
an independent variable for the prediction rule model.  Allowing for a more lenient alpha 
level, rather than the traditional  p-value of ≤ .05,  is recommended during univariate 
analysis to  protect against the elimination of a variable that may have potential predictive 
value during the next step, logistic regression (Aim Two) (Bruce, 2010; Hosmer & 
Lemeshow, 2000).    
 
Specific Aim 2: Integrate the most robust variables associated with CDI in the 
postoperative colectomy patient into a clinical prediction rule model.   
 
This aim was accomplished in two steps.  In the first step, binary logistic 
regression was used to determine the variables to include in the CPR.  For the next step, 
the regression coefficients from the logistical regression were translated into a point-
based scoring system.   
Step 1. 
Direct binary logistic regression was used to determine the variables to be 
included in a CDI prediction rule for postoperative colectomy patients.  The direct 
method of logistic regression allows for evaluation of all the variables simultaneously, 
not in a specified order (sequential logistic regression) or in relation to the statistical 
criteria of the other variables (stepwise logistic regression) (Tabachnick & Fidel, 2007).  
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Since the evidence for risk factors of CDI is just beginning to reflect the new 
epidemiology of the emerging hypervirulent strain of infection, the relative importance of 
the predictor variables to the outcome is still being established.  Therefore, no hypothesis 
about the order or importance of each variable was determined a priori and each predictor 
evaluated equally (Tabachnick & Fidel, 2007).           
Independent variables found to be significantly associated with CDI at p ≤ .15 in 
univariate analysis (Aim One), were entered into the logistic regression model.  A 
significance level of p ≤ .05 was the criterion established for the final model.  Each of the 
variables were tested to see if they were excessively correlated (variance inflation factor 
> 10), with any of the other variables in the model.  Variables that were significantly 
associated (p-value =.05) with the outcome, CDI, in the final model were included in 
creating the CDI prediction rule. 
Although the variable of ASA classification was important to analyze in Aim One 
as a descriptive measure, it was removed from the primary regression analysis (Aim 
Two) because of its association with the other preoperative comorbidity variables 
measured for the model.  Previous investigators have cited strong association between the 
ASA classification and the ACS NSQIP preoperative risk variables (Davenport, et al., 
2006).  In preparation for this analysis, the ASA variable was tested against the 20 
variables of comorbidity.  The ASA score had a statistically significant association with 
every other variable of comorbidity in the model (See Appendix D).  The association 
between the ASA classification variable and the other variables entered into the 
regression model, would have the potential to undermine the effects of the variables on 
the outcome (Tabachnick & Fidel, 2007).  And since the ACS NSQIP risk factors have 
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been found to be stronger predictors of mortality and morbidity than ASA classification 
(Davenport, et al., 2006), the opportunity to investigate the individual contribution of 
these factors in isolation from ASA was critical for building the internal validity of the 
CPR. 
Step 2.  
Using a previously established method (Kinlin, Kirchner, Zhang, Daley, & 
Fisman, 2010; Sullivan, Massaro, & D'Agostmo, 2004), the logistical regression model 
was translated into a clinical prediction rule with a point-based scoring system.  The 
calculation of the point-based scoring system for the CPR was derived from each 
significant regression coefficient in the model divided by half of the lowest regression 
coefficient value.  This method transforms the value of the regression coefficient into 
weighted integers whereby each variable was now assigned ―points‖ reflective of the 
propensity of the risk for CDI in the model.  A total risk score was then summed and 
quantified for the entire spectrum of individual point values (from highest to lowest).  
The predicted probability of each individual risk score was calculated using the equation 
in Figure 3.2.   








While the odds ratios from a standard multivariable logistic regression models give an 
    predicted probability ;       =  exponential function;     = score ;    =  intercept; 
    =  ½ of the smallest regression coefficient 
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estimate of the association between each individual risk factor, such odds ratios cannot 
provide a comprehensive assessment of risk for each individual.  Such an overall 
assessment of risk for each individual patient is provided by clinical prediction rules 
derived from multivariable models, thus making the information from statistical models 
more useful for clinical practice (Sullivan, et al., 2004).  Patients will be divided into high 
and low risk groups based on the distribution of the scores and the associated predicted 
probability.  It is anticipated that the threshold for high risk may be approximately 20%.  
Risk scores for other conditions, most notably the Framingham cardiovascular score, 
which was one of the first scores developed to assess cardiovascular risk, use a threshold 
of 0.20 probability to define high risk (Beswick, Brindle, Fahey, & Ebrahim, 2008; 
Broedl, Geiss, & Parhofer, 2003).  In the Framingham equations, individuals with low 
risk have 10% or less CHD event risk at 10 years, intermediate risk if their probability of 
CHD events is between 10% and 20%, and are defined as high-risk if their probability 
exceeds 20% (Beswick, et al., 2008; D'Agostino, Grundy, Sullivan, Wilson, & Group, 
2001).  Although other research has assigned a risk threshold for CDI as high as 40%, 
this was for the risk of recurrent disease, not primary disease, where the overall risk was 
expected to be much higher (Hu, et al., 2009).  
Specific Aim 3: Evaluate the predictive accuracy of the CDI prediction rule. 
A receiver operating characteristic (ROC) curve analysis was used to determine 
the accuracy of the prediction rule.  As the area under the ROC curve approaches 1.0, the 
accuracy of the prediction rule increases.  The area under the curve of .5 is considered a 
non-informative model and 1.0, a perfect model (Steyerberg, et al., 2008a).  Reviewing 
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the set of statistics related to predictive accuracy, along with the ROC curves, will 
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Chapter IV  
Results 
 
The cohort included 2590 adult patients that were operated on for a colectomy 
involving the removal of a portion of their colon with the CPT codes of open segmental 
colectomy (44140), laparoscopic segmental colectomy (44204), ileocolic resection 
(44160), and laparoscopic ileocolic resection (44205).  Operations took place between 15 
August 2007 and 30 June 2009 at an MSQC participating hospital.  Of the 2590 patients, 
293 (11.3%) were excluded because their surgery was classified as emergent (requiring 
emergency surgical intervention).  Another 17 patients (0.7%) were excluded because 
they were they were outpatients and did not require an inpatient postoperative 
hospitalization.  An additional six patients were removed because the dependent variable 
of CDI was missing.  Finally, a total of 2274 inpatient colectomy patients were included 
for analysis, 55 (2.4%) of which were positive for a postoperative C. difficile stool toxin 
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Figure 4.1.  Flowchart of Colectomy Patient Cohort. 
 
Because the ACS NSQIP has a reputation for high–quality clinical data 
(Hamilton, Ko, Richards, & Hall, 2010), there was minimal incomplete data for any of 
the independent variables (less than 1% total).   Since the number of incomplete data was 
low, cases were assumed random and treated in the likewise deletion method during 
analysis.  Listwise deletion, or the exclusion of cases with missing data, gives valid 
inferences in cases where missing data is minimal and assumed random (Allison, 2001).     
Specific Aim 1:  Determine the significant univariate associations between the 
preoperative risk factors of patients with CDI and without CDI. 
Host Variables. 
Patient characteristics. Significant univariate associations between the 
preoperative risk factors of patients with CDI and without CDI are shown in Table 4.1.  
Patients diagnosed with CDI were more likely to have a higher (i.e. less healthy) 
 
  59 
American Society of Anesthesiologists (ASA) classification (p=.037) but there was no 
association between Age and CDI.  
Table 4.1 
 
Univariate Analysis of Patient Characteristics and CDI 
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Patient Comorbidities.  As seen in Table 4.2, pulmonary and neurological 
morbidities were significantly associated with CDI in this cohort.  Patients with CDI 
demonstrated greater ventilator dependence within 48 hours post surgery (p = .015) and a 
higher association of dyspnea (p=.038) with moderate exercise and at rest.  
Neurologically, CDI was strongly associated in patients with a history of TIA (p=.029), 
but no other neurological variables achieved statistical significance.  Lastly, the number 
of patients with acute renal failure was approaching significance (p=.158) and those on 
dialysis, closer to achieving it (p=.076).   
Table 4.2 
 
Univariate Analysis of Patient Comorbidities and CDI 
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χ2 (Chi Square) Test unless otherwise indicated; a Fisher Exact Test;b t- Test.    COPD= Chronic Obstructive Pulmonary Disease  CHF= Congestive Heart Failure; MI 
=Myocardial infarction; CVA =cerebrovascular accident; TIA =transient ischemic attack; WBC =White blood cells. 
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Treatment-related Variables.  
As indicated in Table 4.3, use of a mechanical bowel preparation was not 
associated with a higher risk of CDI (p=0.785).  Among patients who underwent a 
mechanic bowel preparation, use of preoperative oral antibiotics showed a lower trend 
with CDI than did the omission of oral antibiotics, although this was not statistically 
significant (p=.095).  Unfortunately, there were no patients that had CDI who had 
received greater than four transfusions or packed red blood cells (PRBCs) so there was no 
detectable association.  Additionally, this analysis did not support surgical procedure or 
approach (as designated by CPT codes) as a variable that was associated with CDI 
(p=.632 and p=.506).   
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Table 4.3  
 




No preoperative exposure variables identified in the conceptual model 
demonstrated any statistical significance (See Table 4.4).  A prior operation, length of 
stay before surgery or transfer from another facility failed to confer statistical 
significance greater than ( p  ≤ 0.15).    
  
a Fisher Exact Test 
b
 t- Test 
Chi Square Test unless otherwise indicated. 
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Table 4.4.  
 
 Univariate Analysis of Exposure Variables and CDI 
 
. χ2 (Chi Square) Test unless otherwise indicated; a Fisher Exact Test;b t- Test. 
 
In summary, eight variables were found to be statistically significant (p ≤ 0.15) in 
the univariate analysis (See Figure 4.2).  All the significant variables, with one exception, 
were related to patient comorbidities;   Mechanical bowel preparation with oral 
antibiotics was significant from the treatment-related category.  As mentioned in Chapter 
III, the ASA category was removed from Aim Two.  Therefore, seven out of the eight 
significant variables were retained to integrate into the binary logistic regression model.   
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Specific Aim 2: Integrate the most robust variables associated with CDI in the 
postoperative colectomy patients into a binary logistic regression model. 
 
The binary logistic regression was performed to test the association of CDI with 
the variables found to be statistically significant (p ≤ 0.15) in the univariate analysis 
(dyspnea, ventilator dependent, hypertension, TIA, acute renal failure, dialysis and 
mechanical bowel preparation with oral antibiotics).   
As demonstrated in Table 4.5, ventilator use within 48 hours prior to surgery was 
the strongest predictor of CDI (OR [10.62 ]; CI, 1.60-67.325).  Another pulmonary 
variable, shortness of breath (dyspnea) with moderate activity or rest, did not achieve 
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statistical significance but demonstrated a strong positive trend.  Although the covariates 
of acute renal failure, dialysis and hypertension were found to be associated on 
univariate analysis, none retained significance as an independent predictor.  A history of 
transient ischemic attack (TIA) continued to be a strong independent predictor of CDI 
(OR [2.527]; CI 1.035-6.170).  In summary, only ventilator support and TIA were 
independently associated with CDI as determined by binary logistic regression.  As part 
of the model checking, we examined interactions between the variables and none were 
statistically significant (variance inflation factor <10).   
Table 4.5 
  
Binary Logistic Regression Model to Assess the Effect of Host Variables on CDI (Model I) 
 
OR= Odds ratio; CI=confidence interval. 
CDI=55; Total =2274 
 
When the singular treatment variable (bowel preparation with oral antibiotic) was 
added to the model, only TIA retained its statistical significance.  Bowel preparation with 
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antibiotics was an insignificant predictor of CDI.  In this logistic regression estimation, 
no patients with CDI had acute renal failure or ventilator use which prevented further 
analysis of these associations.  (See Table 4.6).   
 
Table 4.6   
 
Model II: Binary Logistic Regression Model to Assess the Effect of Host Variables and Treatment  




In summary, after adjusting for variables that were statistically significant in the 
univariate analysis, the binary logistic regression revealed ventilator and TIA as the 
strongest independent predictors of CDI in this cohort (See Figure 4.3).  When the 
OR= Odds ratio; CI=confidence interval. 
† Acute Renal Failure variable demonstrated 
insufficient variability  
†† Ventilator variable was a constant; all 1712 patients 
had a value of zero.  
CDI=40; Total = 1712 
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treatment-related variable (bowel preparation with oral antibiotics) was added to the 
model, only the variable of TIA remained statistically significant.  There was no 
statistically significant association between the use of prophylactic oral antibiotics and 
CDI.   
Figure 4.3. Summary of Significant Variables from Binary Logistic Regression (Model I) 
 
Specific Aim 3:  Evaluation of the predictive ability of the CDI prediction rule.   
A CPR point-scoring system was created from the regression coefficients from 
Table 4.5 (Model I).  Although both Model I (Table 4.5) and Model II (Table 4.6) 
demonstrated equivalent measures of goodness of fit (Nagelkerke R Square= .03590 and 
.03578, respectively), Model I was chosen because it included a more generalizable 
patient population (562 additional patients that did not receive bowel preparation) and it 
was the most parsimonious model for CPR development.  The regression coefficients in 
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Model I were transformed into weighted point values and summed for estimates of risk 
for CDI to develop the risk score (see Figure 4.4). 
 




Estimate the parameters of the logistic regression model (regression coefficients and p value, OR and 
CI). 
   
p    OR 
95% CI 
Variable Regression  
coefficient 
Lower Upper 
Acute Renal Failure .178 .895 1.195 .083 17.094 
Dialysis 1.116 .171 3.052 .618 15.077 
Transient ischemic attack 
(TIA) 
.927 .042 2.527 1.035 6.170 
Hypertension (HTN) .227 .45 1.255 .696 2.265 
Ventilator 2.363 .012 10.620 1.675 67.325 
Dyspnea .058 .067 1.786 .960 3.321 
 
2 Set the constant (the number of regression units that will correspond to one point or the intercept). (B0)  
-4.079. 
3 Determine the normalized value for each variable.  The normalized value consists of dividing each 
variable by the lowest valued regression coefficient and rounding to the nearest integer.  In this 
example, the smallest correlation coefficient is the variable of acute renal failure (.178).  Half of the 
lowest value regression coefficient is called Bi in the model.  Half of the smallest regression coefficient 
is .089 (.178/2).   
4 Each variable is then divided by .089 and rounded to the nearest integer.   
Variable 
Regression 
coefficient Divide by .089 Total Integer 
Dyspnea 
.058 
.058/.089 6.51 7 
Ventilator 
2.363 
2.363/.089 26.55 27 
HTN 
.227 
.227/.089 2.55 3 
TIA 
.927 
.927/.089 10.4 10 
Acute Renal Failure 
.178 
.178/.089 2 2 
Dialysis 
1.116 
1.116/.089 12.53 13 
 
5 Sum the individual point values. This score is the “S” in the equation.   
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6 Calculate the estimated predicted probability ( ) for each score, S.  This is the probability of CDI.   
Estimate Predicted probability ( ). 
  
 
               
 
 
          predicted probability ;       =  exponential function;     = score; 
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Each patient (n=2274) in the cohort was then assigned a score based on the 
presence of the weighted variable(s) (See Figure 4.5). The range of scores for the CPR 
was from 1-62, however, within this cohort, the highest score attained was only 35.  The 
mean score was 6.47 for patients with CDI and 3.42 in patients without CDI; the median 
scores were both three.  As demonstrated in Figure 4.6, the patients that had CDI had a 
greater percentage with higher scores. When subjected to the Mann-Whitney U test, the 
results suggested that there was a statistically significant difference between the 
underlying distributions of the scores of CDI patients and the scores of non-CDI patients 
(p ≤ .001). 
 Figure 4.5  The probability of CDI by score. 
 




Figure 4.6  Distribution of CDI risk score in cohort (CDI vs. No CDI). 
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Using the predicted probabilities from Model I, the predictive ability was 
evaluated by the area under the ROC curve.  The area under the ROC curve was 0.628 
(95% CI  0.550-706) (see Figure 4.7). 
 
In this cohort, the probablity of CDI infection ranged from zero (score of one) to 
0.27 (score of 35).   A high risk patient was determined to be at a theoretical probability 
of risk of 0.18 (score of 29) which represented the top quartile of the distribution.  A high 
risk threshold of approximately 20% has precedence in the literature for other risk score 
calculations, most notably the Framingham cardiovascular score which was one of the 
first scores developed to assess cardiovascular risk, use a threshold of 0.20 to define high 
Figure 4.7  ROC Curve for CDI. 
          = Reference line (0.5) 
          =  Area under the curve (.628) 
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risk (Beswick, et al., 2008; Broedl, et al., 2003).  In the Framingham equations, 
individuals with low risk have 10% or less CHD event risk at 10 years, intermediate risk 
if their probability of CHD events is between 10 and 20%, and are defined as high-risk if 
their probability exceeds 20% (Beswick, et al., 2008; D'Agostino, et al., 2001) 
The CPR was then analyzed for measures of sensitivity, specificity, positive 
predictive value (PPV) and negative predictive value (NPV).  The sensitivity and 
specificity for the high risk patients with a score of 29 were 1.8% and 98.7%, 
respectively.  The PPV was 14.3% and NPV was 97.6%.  See Table 4.8 for predictive 
ability of sequential quartile scores of 8.5. 18.5, 29. The sensitivity and specificity for the 
high risk patients with a score of 29 were 1.8% and 98.7%, respectively.  The PPV was 
14.3% and NPV was 97.6%.  See Table 4.7 for the predictive ability for the sequential 
cutoff scores of 5, 8.5. 18.5 and high risk score of 29.  
Table 4.7  
 
























5 1789 430 34 21 38.2% 80.6% 4.7% 98.1% 
8.5 1874 345 39 16 29.1% 84.5% 4.4% 98.0% 
18.5 2186 33 50 5 9.1% 98.5% 13.2% 97.8% 
29 2213 6 54 1 1.8% 99.7% 14.3% 97.6% 
 
TN=true negative; FP= false positive; FN= false negative; TP=true positive;SENS= sensitivity, SPEC= specificity; PPV=positive predictive value; NPV= negative predictive value  
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Chapter V  
Discussion 
Although many recent studies have led to tremendous success in reducing HAIs 
(Bode, et al., 2010; Pronovost, et al., 2006), no equivalent large-scale success has been 
reported to reduce CDI.  The incidence of CDI continues to climb (Dubberke, et al., 
2010; McDonald, et al., 2006), without evidence of a peak or plateau (Dubberke, et al., 
2010), despite the national attention this epidemic has received (Parker-Pope, 2009; 
Sunenshine & McDonald, 2006).  As the threat of CDI continues to escalate, and the 
traditional arsenal of antibiotic regimens are rendered ineffective, new strategies for 
prevention are needed on the front lines of defense.  The purpose of this research was to 
begin the first phase in a series of studies to develop a clinical prediction rule (CPR) for 
the quantification of CDI risk in a population of colectomy surgical patients.  A CPR to 
identify patients most vulnerable to CDI early in their hospitalization is a strategy to 
improve patient outcomes so that preventative interventions and treatments can be 
targeted to at-risk patients before, not in response to, infectious disease.   
The construction of the CPR was achieved through three sequential aims.  In Aim 
One and Aim Two, the risk factors for CDI were identified using univariate and binary 
logistic regression.  The preoperative variables of mechanical ventilation and transient 
ischemic attack (TIA) were found to be the most robust significant predictors of CDI in 
this cohort. In Aim Three, the final multivariate model was transformed into a CPR 
weighted point-scoring system.  The discriminative ability of area under the operator 
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receiver curve was modest at .628.  Depending on the score cutoff the specificity and 
sensitivity of the CPR ranged from 1.8%-38.2% and 80.6%-99.7%, respectively.  This 
study represents the first and largest regionally-based description of preoperative risk 
factors for CDI in surgical patients using a clinical (not administrative) dataset.  
Additionally, through the use of a CPR, the findings of this study have attempted to 
quantify the risk of infection for translation into the clinical environment.  Since surgical 
patients now carry more than twice the burden of HAI than their medical counterparts 
(Sax, et al., 2011), strategies to identify and protect vulnerable patients are becoming 
increasingly more important.   
In order to demonstrate the interrelated variables that contribute to the risk of 
CDI, this chapter is organized around the components of the epidemiological triad of 
infection (pathogen, host, exposure) that served as the underpinnings for the conceptual 
model.  Using the conceptual model as a blueprint for this discussion, the contribution of 
each of the three components is addressed first separately, and then together, where the 
theoretical components of the CPR intersect.  In closing, the implications of this research 
for health care professions, and specifically nurses, are delineated and recommendations 
for a research agenda for CDI CPR are prescribed.  
Incidence of Clostridium difficile Infection 
In this cohort of 2274 surgical colectomy patients in Michigan, the incidence of 
CDI was 2.4%.  This incidence fits squarely within the range of one to six percent 
reported in the literature for similar populations of postoperative colorectal patients 
(Lesperance, et al., 2011; Southern, et al., 2010; Wren, et al., 2005; Zerey, et al., 2007).  
However, comparisons across other surgical populations are difficult since the incidence 
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and consequence of CDI is not uniformly calculated and reported.  Incidence reports of 
CDI are largely based on retrospective analyses (Lesperance, et al., 2011; Southern, et al., 
2010; Wren, et al., 2005; Zerey, et al., 2007) or rely on large administrative databases 
(Lesperance, et al., 2011; Zerey, et al., 2007).  Since the median length of stay for 
colectomy patients is six to seven days (Iyer, Saunders, & Stemkowski, 2009; Schmelzer, 
et al., 2008) and CDI incubation period can exceed this by several weeks (Palmore, Sohn, 
Malak, Eagan, & Sepkowitz, 2005; Sunenshine & McDonald, 2006), there is a greater 
possibility that the true rate of CDI is underestimated.  Further confounding accurate data 
reporting is the fact that many patients with CDI received empiric treatment (when the 
physician may treat for CDI without ordering a definitive test) and are not reported.  
Thus, it is likely the true underlying incidence of CDI is probably higher than current 
estimates presume.  
 Regionally, across Michigan, the rate of CDI among hospital discharges doubled 
between 2002 and 2008 (Verlee, 2011) which is an alarming trend considering the 
propensity for underestimation of detection.  This escalation parallels the national trend 
(Dubberke, et al., 2010) and is likely associated with the more virulent and severe type of 
CDI due to the NAP1/B1/027 strain.  Although this study did not have access to typing of 
strains, unpublished preliminary reports have confirmed the emergence of the 
NAP1/B1/027 strain, and an associated ribotype 020 variant in Southeastern Michigan (S. 
Walk, personal communication, April 24, 2011).  Both of these strains are superseding a 
less virulent strain that characterized CDI before 2003.  Since this research examined a 
cohort of patients between the years 2007 and 2010, it likely captures the contemporary 
trends of the CDI epidemic in this high-risk subset of surgical patients.   
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Host Variables 
 
Although, the variable age is a long-standing and repeatedly validated risk factor 
for CDI (Ang, et al., 2008; Crabtree, et al., 2007; Sunenshine & McDonald, 2006), this 
research did not find any appreciable difference between incidence of CDI and age in this 
cohort (p=0.939) on univariate analysis.  Even when the variable age was divided in to 
dichotomous and categorical variables, no significant association between age and CDI 
could be detected (See Table 5.1).  Being that the evidence for increasing age and CDI 
risk was an atypical finding, additional post hoc analyses were conducted.  When the 
variable of age was added to the final model, there was still no significant association 
between CDI and age ( p= 0.283, (95% CI,  .989-.969)) and the variables of TIA and 
ventilator remained statistically significant.  Furthermore, adjusting for age had a 
negligible effect on the predictive ability of the model (area under the curve .631, (95% 
CI, 0.554-0.709) versus .628, (95% CI, .550-.706) and model fit equivalent measures of 
goodness of fit (Nagelkerke R Square= .038 versus .036).  However, an interesting 
finding was that the variable of dyspnea, close to achieving statistical significance 
previously (p=.067), decreased to less than .05 when age was added to the model (see 
Appendix E).  This suggests that chronological age alone may not be a sufficient 
predictor of CDI risk but may in fact be a surrogate for other measures of frailty, such as 
pulmonary compromise.  Including more defined measures of frailty, such as systemic 
inflammatory biomarkers and inflammatory related diseases (Chang, Weiss, Xue, & 
Fried, 2011), rather than chronological age, may be where more predictive and sensitive 
measures of CDI risk for CPR development will be best ascertained.  
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Table 5.1  
Univariate Analysis of Age as a Continuous, Dichotomous and Categorical Variable 






    p  
 
Continuous  
    
Age 65.41 +/- 15.20 65.41 +/-15.18 65.56 +/- 16.141 .934
b 
     
Dichotomous     .759 
Less than age 65 1080 (47.5) 1055 (47.5) 25 (45.5)  
Greater than age 65 1194 (52.5) 1164 (52.2) 30 (54.5)  
     
Dichotomous     
    Less than age 80 1837 (80.8) 1797(81) 40  (72.7) .125 
    Greater than age 80 437 (19.2) 422 (19) 15 (27.3)  
     
Categorical    .349 
18-39 115 (5.1) 112 (5) 3 (5.5)  
40-49 217 (9.5) 211 (9.5) 6 (10.9)  
50-59 442 (19.4) 432 (19.5) 10(18.2)  
60-69 509 (22.4) 499 (22.5) 10 (18.2)  
70-79 554(24.4) 543 (24.5) 11 (20)  
80-89 373 (16.4) 358 (16.1) 15 (27.3)  
90+ 64 (2.8) 64 (2.9) 0 
 
 
     
χ2 (Chi Square) Test unless otherwise indicated;  b t- Test 
 
 
Another potential explanation for the lack of association between age and CDI in 
this cohort, may be because surgical patient populations are generally younger and 
healthier than their medical counterparts (Southern, et al., 2010).  The average age of a 
patient in this cohort was 65.41.  The average age of patients with CDI in a similar cohort 
of only medical patients, was almost three years higher at 67.9 years-old (Southern, et al., 
2010).  For this reason, chronological age may not be as strong of an independent 
predictive variable for CDI in the elective surgical patient population as in their medical 
counterparts.   
Similarly, although race and gender have both been reported as risk factors for 
CDI in other studies, neither variable demonstrated significance in this analysis.  
Lesperance et al. (2011) identified race as a statistically significant risk factor for CDI 
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when compared with their nondiseased controls but race was analyzed as a dichotomous 
variable (Caucasian vs. non-Caucasian) which may have decreased the variability in the 
sample population.  Similarly, the risk of the female gender, identified as a risk factor in a 
study by Zerey et al (2007) and Crabtree et al (2007) lacked corroboration in other 
surgical cohorts (Crabtree, et al., 2007; Zerey, et al., 2007).  In this study as well, there 
was no statistical difference between male and female genders and CDI risk.  Therefore, 
uncertainty persists as to whether or not race or gender significantly contributes to a 
patient‘s risk of CDI.  
In contrast, this study provides additional validation that patients with a higher 
severity of illness are at a higher risk for CDI.  Patients with comorbidities reflecting a 
higher severity of illness (ventilator use and renal disease) were associated with a greater 
risk of disease. Although the ASA classification was not moved forward to the multiple 
variable regression models due to its association with other risk factors, an additional 
post-hoc analysis was conducted to determine the effect of the final model when 
adjusting for the effects of the ASA classification.  Adjusting for ASA did not change the 
model results, as ventilator and TIA were still the only variables achieving a p- value of ≤ 
.05.  In addition, there were no significant associations between CDI and ASA 
classification when analyzed as a categorical variable (with all five classifications) and as 
a dichotomous variable (classifications ≤ 3 vs. classifications of 4 & 5) nor was there any 
appreciable increase in the predictive accuracy of the model; the area under the ROC 
curve increased only marginally from .628 to .642  (see Appendix F).  
Because the national rate of CDI continues to rapidly increase without a 
concomitant national increase in a population‘s severity of illness (Dubberke, et al., 
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2010), it suggests that a patient‘s severity of illness, while important, is not a singular 
‗stand-alone‘ variable that contributes to CDI risk.  More likely, it is that the severity of 
illness in combination with other risk factors (such as antibiotic usage, proton pump 
inhibitor medication) may have an interactive effect on disease acquisition.   
Since this dataset included a large number of comorbidities, it enabled the 
analysis of the umbrella term of ―severity of illness‖ to be examined with greater detail.  
Respiratory covariates were of particular interest because they are often associated with 
CDI risk.  Rodrigues et al. (2010) identified respiratory disease as an independent 
predictor of CDI and others have identified patients with mechanical ventilation as a risk 
factor of CDI either on univariate (Garey, et al., 2008; Lawrence, Dubberke, Johnson, & 
Gerding, 2007; Rodrigues, et al., 2010) or multivariate analysis (Dubberke, et al., 2007b).  
Although this study identified mechanical ventilation as a strong predictor of CDI, it is 
likely this association is mediated by the increased use of antibiotic therapy.  Patients on 
mechanical ventilation generally have more antibiotic administration therefore, increase 
their risk of CDI.  In other studies that have been able to control for antibiotic usage, the 
association of mechanical ventilation with CDI was either decreased (from an odds ratio 
of 9.7 to 1.9) (Dubberke, et al., 2007b) or removed (Garey, et al., 2008) when subjected 
to multivariate analysis.  Since antibiotic use is likely in the causal pathway for CDI, the 
ability to control for the mediating effect of antibiotic use in this study may have 
produced a similar effect.  
There is more accumulated evidence demonstrating an association between renal 
disease and CDI (Barany, Stenvinkel, Nord, & Bergstrom, 1992; Eddi, et al., 2010; 
Garey, et al., 2008; Kyne, et al., 2002; Pant, et al., 2011).  The association is attributed to 
  82 
a possible decrease or absence of gastric acid (achlorhydria or hypochlorhydria), the dose 
or exposure to dialysis and/or a higher C. difficile pathogen load in the stool due to 
deceased motility (Barany, et al., 1992; Eddi, et al., 2010).  It is also reasonable to 
assume that patients with renal disease or dialysis have had higher exposure to both 
antibiotics and health care facilities, also significant risk factors for CDI.  The fact that 
both renal variables (acute renal failure or treatment with dialysis) were insignificant in 
this population after the regression analysis is surprising given the clinical and empirical 
evidence of renal disease‘s association with CDI.  Eddi et al (2010), conducted an in- 
depth analysis of patients with chronic kidney disease and found only those patients 
suffering from end stage disease carried a risk for CDI (Eddi, et al., 2010).  This may 
help explain the insignificant finding; patients with end stage renal disease are not good 
candidates for surgery and are likely not represented in this cohort.  Renal disease, and 
more specifically end stage renal disease, may be a stronger predictor of CDI in the 
medical patient population.   
Puzzling as it may be, a history of transient ischemic attacks and the subsequent 
development of CDI had a significant and strong association in both univariate and 
multiple variable analysis.  The strong association between TIA and CDI does not appear 
to have any precedence in the literature.  Additionally, no other variables in the central 
nervous system category (cerebral vascular accident, hemiplegia/hemiparesis, impaired 
sensorium) were found to be statistically significant.  If cerebral vascular accident (or 
stroke) and TIA were both significant, the association with CDI could possibly be 
attributed to alterations in intestinal immunity that are hypothesized to occur as part of 
the post-stroke immunodepression sequela (Schulte-Herbruggen, Quarcoo, Meisel, & 
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Meisel, 2009).  However, since only TIA, and not the more severe condition of stroke, 
was the only significant variable in this analysis, support for the immunomodulation 
effects of a cerebral vascular event cannot be fully supported as a possible mechanism for 
association between CDI and cerebrovascular events.  As the stroke-induced changes 
within the intestinal microbiota become better understood, and future research reveals 
more evidence for a link between cerebrovascular events and CDI, the suppression of the 
intestinal population may emerge as a possible antecedent to infection.   
Although the association of TIA with CDI may be a spurious finding, if it is in 
fact true, further independent study will be required to determine possible associated 
mechanisms.  For example, this finding may be linked to a regional practice of 
prescribing drugs such as statins.  Patients with a history of TIA‘s are often prescribed 
statin (HMG-CoA reductase) medication to reduce cholesterol plaques.  The 
hypothesized connection between statins and CDI has been recently addressed in the 
medical literature (McGuire, Dobesh, Klepser, Rupp, & Olsen, 2009) as a possible drug-
disease association.  
The theoretical hypothesis of a drug-disease association as a precursor to CDI has 
gained momentum as the rise in CDI has extended to patients without any previous 
antibiotic exposure.  Without antibiotic exposure, the micro-environment of the 
gastrointestinal tract is left undisturbed.  Thus, theories advocating other unknown 
mechanisms, besides antibiotic exposure, that allow the Clostridium difficile organism to 
take advantage of the microenvironment have gained strength.  The associations between 
drugs that alter gastric acid suppression (proton pump inhibitors and histamine blockers) 
are one such example.  While the statin drug class does not alter gastric acid suppression, 
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it does interfere with an important cellular mechanism on the Rho pathway (unrelated to 
their primary role of cholesterol reduction).  The Rho pathway is described as a type of 
―molecular switch‖ that controls important regulatory cell functions such as cell 
proliferation, inflammation and apoptosis (McGuire, et al., 2009).  When the Rho 
pathway is inhibited or ―shut off‖ it leads to apoptosis of the colonic epithelium.  
Clostridium difficile toxins also inhibit the Rho pathway, although this inactivation 
occurs at a different site.  While the beneficial effects of statins have been described 
(Roberts, Guallar, & Rodriguez, 2007; Zafrir, Laor, & Bitterman, 2010), the influence of 
two agents interrupting the Rho pathways at two different sites is unknown.  Given that 
the number of patients on statins continues to increase (Ma, Sehgal, Ayanian, & Stafford, 
2005), the synergic effects of Clostridium difficile toxins and statin drugs on the different 
sites of the Rho pathway is a hypothesis that deserves further inquiry (McGuire, et al., 
2009).  Only adequately powered prospective studies will be able to decisively identify 
the potential association between any drug-disease association between statins and CDI.  
Treatment-related Variables 
 
The most important finding in the treatment-related category was not what was 
found significant, but what was found insignificant.  Mechanical bowel prep (with and 
without antibiotics) was found to have no association with an increased risk of CDI.  
These results contradict an earlier single-center study (Wren, et al., 2005) and add to the 
debate surrounding mechanical bowel preparation and CDI risk. 
Mechanical bowel preparation (MBP), a long-standing preoperative standard of 
care for colorectal surgical patients, has been called into question as a possible precursor 
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to adverse outcomes, including CDI (Contant, et al., 2007; Guenaga, Matos, Castro, 
Atallah, & Wille-Jorgensen, 2005; Howard, White, Harden, & Ellis, 2009; Slim, et al., 
2009; Wren, et al., 2005).  The implication of MBP as a possible antecedent to CDI is 
because MBP disrupts the normal bowel flora and potentially sets the conditions for C. 
difficile to proliferate (Wren, et al., 2005). Determining an association between the rate of 
CDI and the practice of bowel preparation in this patient population is important because 
two risk factors for CDI, recent antibiotic therapy and disruption of the normal flora of 
the intestines, are direct consequences of bowel preparation.  
In an effort to explore this association with more precision, an additional post hoc 
analysis was undertaken on this dataset (see Appendix G).  Again, the incidence of CDI 
was the same in the patients that received MBP as in those that did not (p=0.95) and the 
same for those that received oral antibiotics with their bowel preparation versus those that 
did not (p=.088).  Even after adjusting for characteristics that achieved p ≤ .05 in 
preliminary analysis, there was no association of CDI with MBP or MBP with or without 
antibiotics (OR [0.96]; CI, 0.50-1.83) and OR [0.60]; CI 0.29-1.23).  Therefore, the 
evidence in this study suggests that abandoning bowel preparation (both with and without 
oral antibiotics) to reduce the risk of CDI is premature and will require additional empiric 
evidence before clinical practice changes should be recommended (Krapohl, et al., 2011).   
Exposure Variables 
 
There is strong evidence to suggest environmental exposure to C. difficile has 
contributed to the increasing incidence of CDI (Cohen, S. H., et al., 2010).  Although the 
three exposure variables analyzed in this study (prior operation, LOS before surgery and 
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transfer from another healthcare facility) were not associated with CDI in this research, it 
would be incorrect to dismiss them as unimportant.  Patients who have had prior surgery, 
have been in the hospital for a longer period of time or have transferred from another 
facility will likely have a greater possibility of being exposed to C.difficile.  The patients 
who become infected with CDI are generally treated and identified.  However, if the 
patients are simply colonized, and not demonstrating signs of infection, they may still 
have the capacity to spread infections to other patients.  Therefore, patients with these 
exposure variables who are colonized (not infected) may not demonstrate an increased 
risk of infection on an individual level, but may have a measurable effect on the 
incidence of CDI on the patients around them (i.e. expose others to infection).  It may be 
possible that the exposure variables measured in this study contribute to CDI risk more 
from a collateral impact, at the hospital-level, than an individual impact.  In order to 
better understand the effects at the hospital-level, a facility identifier as well as the ability 
to determine the type of hospital (medical center, academic or community) would help to 
better understand these influences.  Additionally, the variables in this category should be 
expanded to include, C. difficile pressure, adherence to recommended environmental 
practices and recent emergency department visits (in addition to hospitalizations) all of 
which can help to further identify and  understand the important trends between CDI and 
exposure variables.  
Predicting the Risk of CDI with the CPR 
 
The rule developed for this study, though only in the first phase of development, 
provides preliminary evidence for the variables necessary to quantify the risk of CDI.  
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The results from the CPR suggest host factors contribute, at least modestly, to the risk of 
CDI (area under the ROC curve .628).  A 20% risk of CDI was translated into a score of 
greater than 29 on the CPR scoring system.  Unfortunately, the sensitivity of the test was 
only 1.8% which translates into a 1.8% chance of patients with a score of 29 conferring a 
risk of CDI.  A high specificity (99.7%) is important in detecting patients that are CDI 
negative, but the inability to effectively distinguish the high risk patients is a 
disappointing result of the CPR.  Due to the poor sensitivity and positive predictive value 
of CPR, it is likely the low incidence of CDI in the sample (55 patients or 2.4%) and the 
absence of several variables in the dataset contributed to this finding.  Important 
treatment related variables such as antibiotic use, proton pump inhibitors, tube feeding 
and exposure variables such as type of hospital, adherence to recommended 
environmental practices and staff/patient education may have contributed to the 
disappointing predictive ability in the final model.  Since the causes of CDI are 
multifactorial, the inclusion of these additional variables in the future developmental 
phases of CPR development will help to achieve stronger predictive value and sensitivity.  
The absence of the variable of antibiotic use may be considered by some to be 
particularly problematic considering that it is the most important and influential 
treatment-related variable missing from the model.  However, since over 50% of 
hospitalized patients receive antibiotics (MacDougall & Polk, 2008), the addition of 
antibiotic use in the CPR may not have produced the desired discriminatory effect.  This 
is especially true in this cohort of surgical patients that have probably received antibiotics 
in accordance with the Surgical Care Improvement Project (SCIP) guidelines (Bratzler & 
Houck, 2005).  Other investigators have found including antibiotic use in a CPR to be 
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impractical and have focused instead on risk factors such as type of admission (surgical 
versus non-surgical) and ICU length of stay) both thought to have greater discrimination 
ability (Garey, et al., 2008).  In the future, more specific definitions of antibiotic use 
including type, duration (Garey, et al., 2008) and use prior to hospitalization may prove 
to be more useful predictors of CDI risk.    
Besides incomplete availability of variables, another reason for the modest results 
of the CPR may have been the methodology employed to construct the rule.  There are 
two primary methods to develop point scoring systems for CPRs and the investigator 
determines whether the scoring requires a simple additive effect (points give for a risk 
factor that is present), or a weighted effect using an odds ratio or regression coefficient to 
calculate the score (Garey, et al., 2008).  Since this study choose the latter method, the 
weights of the risk factors from the logistic regression model were quantified based on 
the regression coefficients.  The parameters of the final model were then expanded so that 
the relative weights of the statistically insignificant variables were included in the final 
point system.  Keeping the statistically insignificant variables in the final point system 
calculations, was an attempt to create a scoring system that reflected the strongest fit 
statistics (Nagelkerke R Square= .036) and retain variables believed to have clinical and 
theoretical significance to the final scoring point system.  Otherwise, the score was 
reduced to a 2-predictor model (TIA and ventilator) with a lower fit statistic (Nagelkerke 
R Square= .021).  Increasing the precision of the CPR will require additional prospective 
research to include the variables not included in this data set.   
Because C. difficile does not appear to be responding to the standard infection 
control practices, enhanced measures to protect patients are necessary.  The results of this 
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CPR suggest host variables, without the influence of other treatment-related and exposure 
variables, make a contribution to CDI risk.  Unlike other HAIs that are predominately 
attributed to treatment-related variables such as urinary catheters, central lines, 
mechanical ventilation and surgical wounds, CDI may prove to be an HAI with a greater 
influence of intrinsic risk.  Therefore, efforts to reduce CDI many benefit from an 
infection control strategy that augments standard infection control strategies such as hand 
washing and environmental decontamination, with those that take into consideration the 
comorbidities of the host.  Future current infection control strategies may include 
choosing candidates for the testing of serologic markers and candidates for both passive 
and active immunization (Kelly & Kyne, 2011).  As seen in Figure 5.1, most preventive 
strategies are targeted to reducing exposure rather than increasing patient (host) 
resistance (Cohen, S. H., et al., 2010; Vonberg, et al., 2008).  
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A CPR for CDI is an inexpensive, nonpharmaceutical and noninvasive method to 
incorporate the individual risk of patients into the broader infection control strategy.  
Instead of a horizontal (nonpathogen-directed) infection control strategy that relies on the 
―one-size-fits-all‖ approach, vertical (pathogen-directed) strategies, such as a CPR for 
CDI, are specifically directed to target the unique behavior of the C. difficile organism.  
For example, a preoperative surgical patient scoring at the threshold for high risk, may 
prompt a review of the antibiotic therapy by the antimicrobial stewardship committee, 
initiate standing orders for nurses to send down suspicious stool samples for prompt 
detection and diagnosis and, if not configured on the hospital ward or unit, placed in a 
private room.  Considering the virulence of C. difficile and the consequences of CDI and 
Figure 5.1. Clinical practice interventions to prevent CDI organized around conceptual model. 
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especially, recurrent CDI, interventions that are tailored to the offending C. difficile 
organism may prove to be worthwhile.  If the goal is CDI elimination, not simply CDI 
reduction, implementation of more vertical (pathogen-directed) strategies, such as the 
CPR, are required to operationalize this goal.   
Future Research 
 
The next phase of CPR development for CDI requires a prospective study to 
include the variables missing from this analysis.  Inclusion of additional variables in the 
next phase of research should be able to increase the predictive ability of the CPR and 
build on the preliminary evidence of this study.  Host risk factors to strengthen the 
validity of the CPR include inflammatory bowel syndrome, fecal incontinence and/or 
systemic and serological markers for CDI and whether or not the patient had end stage 
renal disease.   
Additionally, investigation of predictive risk factors that include frailty measures 
such as systemic inflammatory biomarkers and inflammatory-related diseases, rather than 
only chronological age, may prove to be worthwhile specially in this population where 
older patients are disproportionally affected by this disease (McDonald, et al., 2006).  
The specific contributors to frailty, or perhaps frailty itself, could yield important practice 
and research implications for CDI prevention.   
The addition of treatment-related variables would also be expected to increase the 
ability to predict CDI.  Important treatment- related variables such as antibiotic use,  
drug-disease associations (proton pump inhibitors and statins), tube feeding and exposure 
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variables such as type of hospital, adherence to recommended environmental practices, 
CDAD pressure, recent emergency department (ED) visits and prior hospitalizations 
require closer examination, especially in the surgical population (see Figure 5.2).  In 
addition, it would be worthwhile to evaluate whether or not the Braden Scale for 
preventing pressure sores (Bergstrom, Braden, Kemp, Champagne, & Ruby, 1998; 
Bergstrom, et al., 1987; Braden & Bergstrom, 1988) has comparable predictive ability for 
other adverse outcomes such as HAI.  Early, but unsubstantiated evidence, suggests that 
the predictive ability of a CPR for infection and a CPR for pressure sores may overlap 
(Tanner, et al., 2009).   
Figure 5.2. Conceptual Model of Clostridium difficile Infection Risk with Independent Variables  
                 
* Analyzed (black) and missing (red).Abbreviations: BMI= body mass index; ASA= The American Society of Anesthesiology ; 
LOS=length of stay; ER= emergency room; CPT code= Current Procedural Terminology Modification code 
Although this study focused only on the preoperative risk factors of CDI Host, 
Treatment-related and Exposure, investigation of the intraoperative and postoperative 
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processes of care are also critical factors for understanding the precise contributions of 
CDI risk.  The ability to isolate the day of CDI diagnosis in relation to the surgery could 
yield important clues as to the where the burden of infection is greatest.   For example, if 
the majority of the patients in this study had contracted their infection during the later 
portion of their 30- day data collection window, precursors to infection may be attributed 
to use of post operative antibiotic dispensing  for SSI‘s or other additional postoperative 
treatments after the postoperative period.   In contrast, a determination of CDI infection 
during the hospital stay, or shortly thereafter, would imply that the risk factors for 
infection are closer to the surgical procedure itself.  The ability to determine the precise 
window of CDI diagnosis is an important consideration for isolating the unique processes 
of care that contribute to the overall risk and has significant potential to inform future 
research.  
For additional research conducted as part of the regional collaborative, data 
elements that are de-identified but include hospital-level information will make it 
possible to assess and adjust for any effects of clustering within hospitals.  Efforts to 
correct for the clustering of effects within hospitals may be able to provide more 
definitive information for predictive risk factors and increase the confidence in the 
statistical findings.  Future analysis using ACS NSQIP data may consider constructing 
variables from the preoperative patient comorbidity data elements in order to increase 
ability to determine additional potential associations.    
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At a national level, dedicated funding of the incidence and deadliness of HAI (to 
include CDI) should be better aligned with the resources available.  For example, despite 
the large morbidity and mortality of HAI, there is substantially less funding for CDI than 
for other diseases such as HIV/AIDS (Donskey, 2011).  Also at the national level is the 
impact of new CMS regulations that restrict reimbursement to hospitals for the cost of 
preventable patient injury and infection (Centers for Medicare and Medicaid Services, 
2009).  Although the policy does not currently include CDI, continuous assessment of the 
consequences of the new regulations at the local level will be necessary.  Will it bring 
about a lasting change in the hospital culture?  Increase preventive antibiotic treatment 
and inadvertently cause antibiotic resistance? Or, even worse, drive the reporting of the 
incidence of HAI underground?  These are all emerging research questions that will 
require thoughtful analysis if the CMS regulations are expanded to include CDI.   
Clinical Implications 
Since HAI is the most common, problematic and avoidable adverse outcome a 
patient will have during their hospitalization, a more thorough assessment of HAI risk is 
overdue.  HAI can no longer be attributed to simply ―the cost of doing business,‖ and 
nurses, at the bedside 24/7, are well positioned to influence change in this practice.  
CPR‘s are a potential strategy nurses could easily implement into practice in order to 
strengthen assessments, identify high-risk patients and guide preventative nursing 
interventions.  And since CPR‘s build on a core of nursing practice, strong assessment 
skills, they have the potential to provide broader, deeper and sustained improvement in 
reducing HAI.  Translating the risk of HAI into a simple, quantifiable, standardized 
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score, via a CPR, would provide a nurse-driven strategy to tailor the environment for a 
patient‘s individual risk.   
As suggested from the findings of this study, a CPR may be particularly useful in 
reducing the risk of CDI in colectomy surgical patients since the burden of risk may be 
influenced more by individual patient comorbidities than other device-related HAI such 
as urinary tract and central line-associated infections.  For postoperative high-risk 
surgical colectomy patients, pro-active nursing interventions could include: (1) allocation 
of private bed space (if not routinely available) (2) standing nursing orders for initiating 
stool specimen collection and processing, (3) preemptive isolation (4) cohorting nursing 
of staff and/or patients (5) reinforced education to patients and visitors.  These 
interventions, introduced prior to infection, not in response to it, represent an opportunity 
for nurses to influence the elimination of CDI by bolstering the traditional boundaries of 
defense.  Unlike the medical profession that is focused on aggressive treatments, nurses 
are uniquely positioned to focus on the foremost weapon against CDI - primary 
prevention.   
Finally and perhaps most important, is the understanding nurses have about the 
human consequences of CDI.  While there is a plethora of literature that focuses on the 
economic costs of CDI such as length of stay and reimbursement shortfalls, rarely, if ever 
is there mention of the human cost of infection.  Nurses are firsthand witnesses to the 
pain and suffering of the infection and the disruption to the normal rhythm of daily 
personal and professional life.  The incontinence and urgency of bowel function is not 
only inconvenient, but exposes the patient to feelings of embarrassment and shame 
(Madeo & Boyack, 2010).  Placing a patient in isolation, as the term describes, puts the 
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patient at risk for loneliness and perhaps even a potential for increased adverse events 
(Abad, Fearday, & Safdar, 2010; Morgan, Diekema, Sepkowitz, & Perencevich, 2009; 
Stelfox, Bates, & Redelmeier, 2003).  And the debilitation and fatigue that often 
accompanies severe CDI compounds the seriousness of a patient‘s condition already 
weakened by underlying illnesses or recent surgery.  A patient with recurrent CDI 
describes his experience in this excerpt: 
This illness has been very distressing. Sometimes I would be on the 
toilet and think I am done.  I get about halfway back to the bedroom, 
then I have to go back again.  Sometimes this would happen 3 times 
in a 15 minute period….I wouldn‘t wish this illness on anybody.  C. 
difficile is one of the most terrible things that I have been dealing 
with my whole life and I have dealt with a lot of things since my 
kidney transplant .  I hope this latest regimen of pills will cure me 
because I am going out of my mind. (Kelly, 2009, p. 955) 
 
Ensuring patient comfort, dignity, and quality of life is the foundation 
of nursing practice.  Dedication of greater resources and attention to prevent 
infection, rather than treating infection, is where nurses can keep this 
foundation strong and eliminate the avoidable pain and suffering of CDI.  By 
leveraging existing data that is already available and collected, CPR‘s offer 
an opportunity to better inform bedside clinicians and target preventative 
interventions to the patients that will receive the greatest benefit. 
Limitations 
The limitations of this study are consistent with those inherent in conducting a 
retrospective analysis and in those operating within the constraints of the MSQC, ACS 
NSQIP dataset.  Since the dataset was restricted to only those variables that were 
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collected as part of the ACS NSQIP and the MSQC Special Colectomy project, this study 
was unable to account for several important variables that would have likely made the 
model and CPR more robust (see Figure 5.2).  This is an important and significant 
limitation that may have confounded the results.   
Although the ACS NSQIP data set contains a rich pool of preoperative 
morbidities, consolidating some of the less frequent comorbidities (with occurrences less 
than five percent) may have been able to reveal stronger associations.  Generally, the 
power of the analysis is reduced when the expected frequencies are less than one or when 
more than 20% of the variables have five or less cases (Tabachnick & Fidel, 2007) .  
Therefore, important potential associations may have been missed.  Consolidation of 
subsets of patient comorbidities into constructed variables such as ‗cerebrovascular 
events‘ or ‗cardiac conditions,‘ may have been able to determine a stronger association 
with the outcome.   
Additionally, with the intent to protect the privacy of the participating hospitals, 
no variable was included in the data set that identified individual hospitals.  This made it 
impossible to assess or adjust for any effects of clustering of hospitals or of patients 
within hospitals.  Lack of a hospital identification variable prevented the validation of 
one of the critical assumptions of logistical regression, independence of observations 
(Tabachnick & Fidel, 2007).  It is important to note that the opportunity to correct for the 
clustering effects in this investigation would have likely increased the error terms 
(standard error) and attenuated the statistical conclusions (Panageas, Schrag, Riedel, 
Bach, & Begg, 2003).   Efforts to correct for the cluster-effects in future research will 
provide more definitive insights for the association of CDI and patient risk. 
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Although the methodology of ACS-NSQIP sampling protocol is carefully 
designed, sampling only the first seven surgeries from each month could invite selection 
bias.  While it is still possible that some selection bias may have been introduced by not 
including every case from every hospital, narrowing the study to only elective cases 
makes it more likely that the similarities of any missed cases differed little from the 
recorded cases.   
An important limitation in the design of the investigation is the possibility that 
some patients may have been lost to follow-up or seen subsequently outside of the 
collaborative hospitals.  This would inadvertently diminish the incidence of CDI 
postoperative cases detected in this dataset.  To reduce the possibility that postoperative 
CDI cases were missed, a 30-day follow-up by trained and dedicated surgical clinical 
reviewer‘s (SCR) (rather than reliance on discharge diagnoses from administrative 
databases) reduces the risk of missed post-operative CDIs.  
 There are three important shortfalls surrounding the definition and interpretation 
of CDI that deserve mention:  (1) the reliance on only confirmed results of lab values (no 
empiric treatment or confirmation with diarrheal symptoms), (2) the necessity to 
distinguish the timeframes for diagnosis and (3) a more specific case definition for 
interfacility comparison of CDI.  By limiting the definition of CDI as only those 
confirmed lab results of C. difficile toxin assay or culture, it is likely that some patients 
were treated empirically without evidence of infection.  However, this situation 
represents what occurs in normal practice, during which a certain proportion of CDI will 
be empirically treated and a certain proportion will be under-diagnosed.  Along the same 
lines, this study could not account for those patients that were only colonized with C. 
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difficile (tested positive) but did not exhibit diarrheal symptoms (not infected).  The 
overall influence of patients that were only colonized, not infected, with C. difficile is 
believed to be minimal, if any at all, since these patients do not qualify for testing without 
the requisite diarrhea episodes.   
 Similarly, the definition of CDI in this study did not include any time frame for 
diagnosis.  This is important to distinguish since patients with less than a 48 hour window 
of CDI diagnosis may be patients with a community-associated CDI rather than a true 
health care associated infection.  Establishing a time frame for diagnosis would also be 
helpful to determine the processes of care that may have had a moderating influence on 
the outcomes (such as increased antibiotic use for patients on ventilators).   Additionally, 
but probably highly unlikely, are patients that may have had an admission diagnosis of 
CDI misrepresented as a postoperative outcome.  Finally, interfacility comparisons of 
CDI should include a case definition that includes the number of patient days as a 
denominator since the risk of CDI increases as the length of stay increases (Cohen, S. H., 
et al., 2010).   
A widespread limitation of studying CDI in multiple inpatient locations is the 
failure to account for the different diagnostic testing techniques used within each hospital 
or contracted testing laboratory.  Because diagnostic detection techniques were not 
standardized at the 24 hospitals in the MSQC, underestimation or overestimation of CDI 
could be a confounding variable for this study.  A survey of the hospital sites at the 
initiation of the study in 2009, revealed that only one hospital site had switched to the 
more specific and sensitive PCR methodology.  The majority of the sites reported using 
the enzyme immunoassay (EIA) toxin A and B diagnostic technique with a reported 
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sensitivity of about 80% (Gerding, 2010).  As the demand for the more sensitive testing 
of C. difficile grows and the adoption of standardized testing techniques increases, this 
limitation will diminish in importance in future research. 
Finally, the derivation and validation of the CPR was performed on the same 
cohort, however, the derivation of the CPR would best be validated on a different patient 
population.  In this study, we derived the CPR and validated the rule on the same patient 
cohort.  In order to generalize the results of the CPR to a wider patient population, the 
development and validation of the CPR on other patient populations is necessary to 
strengthen and refine predictive accuracy. 
Conclusions 
At the turn of the century, the most common cause of illness and death were from 
infectious diseases such as polio, small pox and influenza.  With the onset of effective 
antibiotic therapy, morbidity due to infectious disease has been replaced with chronic 
disease conditions such as cancer, heart disease and diabetes.  But the escalation in the 
number of pathogens resistant to traditional antibiotic treatments is a reminder of the 
persistent and challenging threat of infectious diseases, like CDI, that are reemerging 
with increasing virulence.  This point is underscored by Richard Krause, MD, in his book 
titled ―The Restless Tide: The Persistent Challenge of the Microbial World,‖ where he 
describes a future of a constant and unrelenting struggle to contain infectious disease 
(Krause, 1981).  When AIDS emerged one year after the book‘s completion, his foresight 
proved disturbingly accurate.  Being that the microbial world holds the evolutionary 
advantage in its ability to mutate and multiply at a rapid rate, and with the pipeline of 
new antibiotic development is stalled (Gardam, Lemieux, Reason, van Dijk, & Goel, 
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2009), the traditional focus on curative treatment must be matched with an equally 
aggressive approach to prevention.  In the battle of the infectious diseases that are 
healthcare acquired, only with a shift to a more comprehensive and proactive focus on 
primary prevention, will the catchy slogan of ―chasing zero,‖ become a reality.   
Although not currently available, a clinical prediction rule to identify those at the 
greatest risk for HAI, may be a cost-effective, nontechnological, and nonpharmaceutical 
approach to translate evidence-based research into clinical bedside practice.  This 
approach moves the nursing process ―upstream,‖ so that environmental challenges can be 
modified and /or individual defenses strengthened.  As the results of this study suggest, 
the intrinsic factors of the host are significant predictors of infection risk and the ability 
to identify, recognize and quantify this risk provide an opportunity to prevent infection, 
not respond to it.  An infection is sometimes likened to a war where a patient is 
relinquished to ―fight‖ or ―battle‖ an infection.  But, one could argue that true victory is 
achieved only when an infection is averted.  In the words of Sun Tzu, an ancient Chinese 
military general and philosopher from over 3000 years ago,      
“For to win one hundred victories in one hundred 
battles is not the acme of skill. To subdue the enemy 
without fighting is the acme of skill.” (Griffith, 1963, 
p. 94) 
Because nurses are uniquely positioned at the bedside 24/7, they are a powerful arbiter to 
prevent infection and will be a powerful force to stem the unrelenting, persistent and 
unforeseen tides of the future.   
 




Appendix A.    Summary of Research Studies 
 
Title Purpose Design Setting/Sample Results Comments 
Clostridium difficile-
associated disease in a 
setting of endemicity: 
Identification of novel 
risk factors (Dubberke,  







382 had CDAD. 
Barnes-Jewish 
Hospital; 
January 1, 2003, 
through December 
31, 2003.   
Independent risk 
factors: increasing age, 
admissions in the past 
60 days, 
hypoalbuminemia, 
leukemia or  
lymphoma, mechanical 
ventilation, gastric acid 
suppression, IV 
vancomycin, 1st, third 
or 4th generation 
cephalosporins. 
Increasing CDAD 









pressure as a risk factor 
for C difficile-associated 
disease 




pressure as a 







382 had CDAD. 
Barnes-Jewish 
Hospital; 
January 1, 2003, 
through December 
31, 2003.   
CDAD pressure may be 
an independent risk 
factor for CDAD. Future 
studies that evaluate 
risk of CDAD should 
control for CDAD 
pressure.  Adjusted for 
demographics, severity 












severity as a major risk 
factor for nosocomial 
Clostridium difficile 


















cohort (n=252). An 
urban teaching 
hospital affiliated 
with a medical 
school. 
Primary cohort:  The 
rate of C diff increased 
with increasing disease 
severity, age and renal 
disease.  Secondary 
cohort: rate of C diff 
increased with transfer 











The burden of 
Clostridium difficile in 
surgical patients in the 




estimate of the 








8113 with CDI; 997 
hospitals in 37 
states.  
Highest incidence of 
CDI: Age >64, 
Medicare, Northeast 
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colectomy, small bowel 
resection and gastric 
resection were 
associated with the 




of LOS (16 days), 3.4 
fold increase in the 
mortality rate.  Also 





resections.   
Acquisition of 
Clostridium difficile and 
Clostridium difficile –
associated diarrhea in 
hospitalized patients 
receiving tube feeding. 













patients had a greater 
risk of CDI.  Postpyloric 
tube feeding had 
highest risk.  Duration 
of surveillance (time in 
hospital) was identified 
as a predictive risk 
factor 
 
Lack of association 
between the increased 
incidence of Clostridium 
difficile associated 
disease and the 
increasing use of 
alcohol-based hand 
rubs. (Boyce, Ligi, 












Observational Measured the 
number of liters of 
ABHR used per 






No evidence that the 
incidence of CDAD 
increased with increase 
in alcohol-based hand 
rubs. 
 
Evaluation of hospital 











discharge of a 
patient with 






N = 1844, 134 
cases of CDI 
Medical intensive 
care unit (MICU), 
Tertiary care 
hospital 
A prior room occupied 
with a patient with CDI 
is a significant risk 
factor for CDI 
acquisition. 
 
A clinical risk index for 
Clostridium difficile 
infection in hospitalized 
patients receiving 
broad-spectrum 






those at high 
risk for CDI 
Retrospective 
cohort 
N= 54,226, and 392 








LOS in ICU. 
 
The effect of hospital-
acquired Clostridium 
difficile Infection on 
Hospital mortality 









2009.  Ottawa 
Hospital 
CDI was independently 
associated with an 
increased risk of death.  
Patients with CDI were 
older, had more 
comorbidities, inpatient 
admissions, ER visits 
and more likely to be 
admitted urgently. 
 
Use of Hypochlorite 
Solution to Decrease 
Use of 
hypochlorite 
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Title Purpose Design Setting/Sample Results Comments 
Rates of Clostridium 
difficile–Associated 
Diarrhea. (McMullen, et 
al., 2007) 
solution to 
reduce rate of 
CDI 
university‐ affiliated 
tertiary care facility 
with a bleach solution 
in both a MICU and 
SICU reduced the rate 
of CDI.  
The acquision and 
outcome of ICU 
acquired C. diff in a 
single center in the UK 






N= 62 patients, 
Single center; April 
2004-April 2007. 
Increasing age, 
APACHE score and 
gender associated with 
mortality (univariate 
analysis).  Age is an 
independent predictor 
of mortality.   
Risk factors 
for mortality  
Clostridium difficile in 
cardiac Surgery: Risk 
Factors and Impact on 
Postoperative Outcome 
(Crabtree, et al., 2007). 
Identify 
preoperative 





N= 8,405 , 66 
patients with CDI;  
incidence of 
0.79% (0.70% at 
institution A and 
1.09% at institution 
B), 
Independent prognostic 
factors for CDI by 
multivariate analysis 
included advancing 
age, female sex, blood 
product transfusion and 
increasing cumulative 
days of antibiotic 
administration.  
Data goes 






















hospitalization and low 
albumin.  Risk of CDAD 
particularly strong for 
high risk antibiotics- 3rd 




imipenim/meropenim.   
Postoperative 
CDI is a 
disease that is 
different from 








The morbidity of 
Clostridium difficile 
infection after elective 
colonic resection- 
results from a national 
population database. 






















N= 695,010. CDI 
occurred in 1.4% of 
patients Single 




CDI associated with 
higher pulmonary 
gastrointestinal 
complications as well 
as an increased length 
of stay and mortality. 
CD colitis patients more 
frequently held 











Mortality and risk 
stratification in patients 
with Clostridium difficile 
-associated 







N= 158 CDI ; 
single-center, large 
teaching hospital 
Increased risk of 
mortality with age over 
80, ASA score 3-5, 
leukocytosis, low C 
reactive protein and 
hypoalbuminemia.  
General surgical 
patients were younger 
than medical patients 






positive stool:  A 
retrospective 
Determine risk 




patients with CDI; 
Single institution. 
Significant risk factors: 
history of CDI, bed 
adjacent to CDI patient 
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Title Purpose Design Setting/Sample Results Comments 
examination of risk 




or same room, severity 
of illness (Horn’s 
index), multiple 





Fluoroquinolones as the 
Predominant 
Risk Factor for 
Clostridium difficile–
Associated 
Diarrhea (Pepin, et al., 
2005) 








of care (5619 
patients).  CDI in 
293 patients.  




emerged as the most 




















N= 21,371; 101 
(0.47%) with CDI; 











Identification of risk 




following treatment of 
polymicrobial surgical 
infections(Metzger, et 
al., 2010)  
Identify risk 









N= 4178 surgical 
infections, 98 with 
CDI 
Only age and APACHE 
II were independently 




antibiotics in colorectal 
surgery increase the 
rate of Clostridium 
difficile colitis (Wren, et 
al., 2005) 
Determine if 




results in a 





 n=304  (13 
women) ;  Single 
institution 
CDI higher in patients 
who received oral 
antibiotics (7.4%) when 
compared with patients 
that did not receive oral 
antibiotics (2.6). No 
differences for the 
variable of cathartic 
type 
 
Specific risk factors for 
Clostridium difficile-




(Vesta, et al., 2005) 
 











 There were no 
significant differences 
in antibiotic use 
between cases and 
controls.  Severity of 
illness (Horn’s Index) 




difficile toxin in 
hospitalized patients 
with antibiotic-
associated diarrhea  















Significant risk factors : 
Impaired functional 
capacity, watery 
diarrhea, use of a 
proton pump inhibitor, 





Chronic kidney disease 
as a risk factor for 
Clostridium difficile 
infection 














prevalence of chronic 
kidney disease and 
CDI.  Patients with end-
stage renal disease 
were significantly 
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Appendix B.  Michigan Surgical Quality Collaborative (MSQC) Colectomy Project Data Collection 
Tool 
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    Appendix C.  Operational Definitions of MSQC Variables 
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ASA  * Dyspnea- Binary 0.000 0.000 
 
 





ASA  * Severe COPD history 0.000 0.000 
 
 
ASA * CHF within 30 days 0.000 0.000 
 
 





ASA  * Previous cardiac surgery 0.000 0.000 
 
 
ASA  * Angina 0.000 0.000 
 
 
ASA * Hypertension 0.000 0.000 
 
 










ASA * CVA/ no neurologic deficit (history)  0.000 0.000 
 
 
ASA * Hemiplegia or Hemiparesis 0.000 0.000 
 
 
ASA * TIA (history) 0.000 0.001 
 
 
ASA * Acute Renal Failure 0.000 0.000 
 
 
ASA  * Currently requiring or on dialysis 0.000 0.000 
 
 
ASA * Disseminated Cancer 0.000 0.515 
 
 





ASA  * Chemotherapy (within 30 days) 0.726 0.842 
 
 
ASA * Radiotherapy (within 90 days) 0.416 0.089 
 
 
ASA * Diabetes 0.000 0.000 
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Appendix E.  Post-Hoc Analysis of Clostridium difficile Infection Adjusted for Age 
 
A. Binary Logistic Regression Model to Assess the Effect of Host Variables on CDI 
Adjusted for Variable of Age.   
 95% CI 
Variable Regression 
coefficient 
p OR Lower Upper 
Acute Renal 
Failure 
.216 .871 1.241 .092 16.795 
Dialysis 1.113 .166 3.045 .629 14.739 
Transient 
Ischemic Attack 
1.010 .029 2.745 1.108 6.803 
Hypertension .346 .284 1.413 .750 2.663 
Ventilator 2.314 .014 10.115 1.607 63.676 
Dyspnea .644 .046 1.904 1.010 3.588 
Age -.011 .283 .989 .969 1.009 















.631 .554 .709 
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Appendix F.  Post-Hoc Analysis of Clostridium difficile Infection Adjusted for ASA Classification 
Binary Logistic Regression of Model I to Assess the Effect of Host Variables on CDI 








   
 
 
  ROC Curve for Model I Adjusted for Variable of ASA (Score of ≤ 3 vs. Score 4,5). 
 
Binary Logistic Regression of Model I to Assess the Effect of Host Variables on CDI 
Adjusted for Variable of ASA Score. 
  
 95% CI 
Variable Regression  
Coefficient 
p OR Lower Upper 
Acute Renal 
Failure 
.087 .948 1.091 .081 14.726 
Dialysis .974 .237 2.649 .527 13.302 
Transient 
Ischemic Attack 
.896 .050 2.450 .999 6.006 
Hypertension .205 .497 1.228 .679 2.221 
Ventilator 2.013 .042 7.488 1.080 51.906 
Dyspnea .500 .127 1.649 .867 3.138 
ASA  
(≤ 3 vs. 4,5) 
.502 .286 1.652 .657 4.154 
Constant -4.585   
  








.642 .568 .715 
  111 
 
 95% CI 
Variable Regression 
coefficient 
p OR Lower Upper 
Renal -.014 .993 .986 .047 20.549 
 
Dialysis 
.999 .228 2.717 .535 13.794 
Transient 
Ischemic Attack 
.929 .044 2.533 1.024 6.266 
 
Hypertension 
.269 .399 1.309 .700 2.448 
Ventilator 1.994 .077 7.342 .803 67.098 
Dyspnea .547 .107 1.728 .889 3.360 
ASA Class 1 
(Reference)  
.812 
   
ASA Class 2 -.141 .947 .869 .014 55.314 
ASA Class 3 -.567 .761 .567 .015 21.798 
ASA Class 4 -.732 .694 .481 .013 18.444 
ASA Class 5 -.182 .920 .834 .024 28.956 
Constant -3.494   
  
 














.642 .568 .715 
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Appendix G.  Post-Hoc Analysis of Mechanical Bowel Preparation and Clostridium difficile infection 
 











Age 65.61 +/- 14.54 64.84 +/- 17.05 .331 
Body mass index 28.36 +/- 6.31 27.35 +/- 5.83 .001 
Sex   .113 
    Male 836 (49.6) 264 (45.7)  
    Female 849 (50.4) 314 (54.3)  
Race/ Ethnicity   .135 
White 1259 (74.7) 449 (77.8)  
Other 426 (25.3) 128 (22.2)  
Preoperative functional status   .000 
Independent 1603 (95.1) 513 (88.8)  
Dependent  82 (4.9) 65 (11.2)  
Type of Resection   .000 
segmental 1157 (68.7) 324 (56.1)  
ileocolic 528 (31.3) 254 (43.9)  
ASA   .000
a 
  1= No Disturbance 27 (1.6) 11 (1.9)  
  2= Mild Disturbance 860 (51.0) 256 (44.3)  
  3= Severe Disturbance 723 (42.9) 262 (45.3)  
  4= Life Threatening 74 (4.4) 45 (7.8)  
  5= Moribund 1 (0.1) 4 (0.7)  
 Dyspnea   .289 
    None 1425 (84.6) 478 (82.7)  
    Moderate or at rest 260 (15.4) 100 (17.3)  
Chronic obstructive pulmonary disease   .427 
Yes 101 (6.0) 40 (6.9)  
No 1584 (94.0) 538 (93.1)  
Pneumonia   .999
a 
Yes 6 (0.4) 2 (0.3)  
No 1679 (99.6) 576 (99.7)  
Congestive heart failure   .000 
     Yes 16 (0.9) 20 (3.5)  
     No 1669 (99.1) 558 (96.5)  
History of myocardial infarction   .023 
Yes 15 (0.9) 12 (2.1)  
No 1670 (99.1) 566 (97.9)  
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Acute Renal Failure   .001
a 
Yes 1 (0.1) 6 (1.0)  
No 1684 (99.9) 572 (99.0)  
Dialysis   .186
a 
Yes 11 (0.7) 7 (1.2)  
No 1674 (99.3) 571 (98.8)  
Steroid Use   .003 
Yes  57 (3.4) 36 (6.2)  
No 1628 (96.6) 542 (93.8)  
Malnourished (>10% Loss of body 
weight) 
  .191 
Yes 61 (3.6) 28 (4.8)  
No 1624 (96.4) 550 (95.2)  
Disseminated CA   .108 
Yes 52 (3.1) 26 (4.5)  
No 1633 (96.9) 552 (95.5)  
Bleeding Disorder   .000 
Yes 72 (4.3) 47 (8.1)  
No 1613 (95.7) 531 (91.9)  
Transfusions   .001
a 
Yes 4  (0.2) 9 (1.6)  
No 1681 (91.8) 569 (98.4)  
Sepsis   .000 
Yes 60 (3.6) 88 (15.2)  
No 1625 (96.4) 490 (84.8)  
Transfer from another healthcare facility   .011 
Admitted from home 1661 (98.6) 560 (96.9)  
Transferred from an acute care 
hospital 
9 (0.5) 9 (1.6)  
Transferred from a chronic care facility 14 (0.8) 6 (1.0)  
Other 1 (0.1) 3 (0.5)  
    
    
    
a Fisher exact test; parentheses denote column percentages*Patients with only fleet enema 
were considered not to have bowel preparation 
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Table 1. Patient characteristics and comorbidities of use of oral antibiotics 















N = 1001(59%) 
p-
value 
Age 65.07 +/- 13.93 65.98 +/- 14.93 .203 
Body mass index 28.72 +/- 6.411 28.11 +/-6.24 .052 
Sex   .041 
    Male 360 (52.6) 476 (47.6)  
    Female 324 (47.4) 525 (52.4)  
Race/ Ethnicity   .000 
White 563 (82.3) 696 (69.5)  
Other 121 (17.7) 305 (30.5)  
Preoperative functional status   .093 
      Independent 600 (95.1) 945 (94.4)  
      Dependent 84 (4.9) 56 (5.6)  
Type of Resection   .000 
segmental 534 (78.1) 623 (62.2)  
ileocolic 150 (21.9) 378 (37.8)  
ASA   .656a 
  1= No Disturbance 8 (1.2) 19 (1.8)  
  2= Mild Disturbance 349 (51.0) 511 (51.0)  
  3= Severe Disturbance 299 (43.7) 434 (42.4)  
  4= Life Threatening 28 (4.1) 46 (4.6)  
  5= Moribund 0 (0.0) 1 (0.1)  
 Dyspnea   .454 
    None 573 (83.8) 852 (85.1)  
    Moderate or at rest 111 (16.2) 149 (14.9)  
Chronic obstructive pulmonary disease   .999 
Yes 41 (6.0) 60 (6.9)  
No 643 (94.0) 941 (94.0)  
Pneumonia   .043a 
Yes 5 (0.7) 1 (0.1)  
No 679 (99.3) 1000 (99.9)  
Congestive heart failure   .220 
     Yes 4 (0.6) 12 (1.2)  
     No 680 (99.4) 989 (98.8)  
History of myocardial infarction   .313 
Yes 8 (1.2) 7 (0.7)  
No 676 (98.8) 994 (99.3)  
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Acute renal failure   .999a 
Yes 0 (0.0) 1 (0.1)  
No 684 (100.0) 1000 (99.9)  
Dialysis   .133a 
   Yes 7 (1.0) 4 (0.4)  
   No 677 (99.0) 997 (99.6)  
Steroid Use   .050 
Yes  16 (2.3) 41 (4.1)  
No 668 (97.7) 960 (95.9)  
Malnutrition (>10% l oss of body weight)   .073 
   Yes 18 (2.6) 43 (4.3)  
   No 666 (97.4) 958 (95.7)  
Disseminated CA   .239 
Yes 17 (2.5) 35 (3.5)  
No 667 (97.5) 966 (96.5)  
Bleeding Disorder   .773 
Yes 28 (4.1) 44 (4.4)  
No 656 (95.9) 957 (95.6)  
Transfusions   .651a 
Yes 1 (1.1) 3 (0.3)  
No 683 (99.9) 998 (99.7)  
Sepsis   .012 
Yes 15 (2.2) 45 (4.5)  
No 669 (97.8) 956 (95.5)  
Transfer from another healthcare facility   .357a 
Admitted directly from home 674 (98.5) 987 (98.6)  
Transferred from an acute care 
hospital 
2 (0.3) 7 (0.7)  
Transferred from a chronic care facility 7 (1.0) 7 (0.7)  
Other 1 (0.1) 0 (0.0)  
aFisher’s exact test; parentheses denote column percentages  
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Bowel Preparation    0.948 
Yes 1685 
(74.5%) 
1645 (74.5%) 40 
(74.1%) 
 



















Bowel Preparation    .088 
with oral antibiotic 684 (40.6%) 673 (40.9%) 11 (27.5%)  
without oral antibiotic  1001 
(59.4%) 
972 (59.1%) 29(72.5%) 
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Table 5.  Bivariate and multiple variable analyses of mechanical bowel preparation 
and oral antibiotics on Clostridium difficile infection. 
 
Variable 
Unadjusted Odds Ratio, (95% 
confidence interval [CI]) 
Adjusted*** Odds Ratio 
(95% CI) 
Use of mechanical 
bowel preparation* 
OR=.980 (0.53-1.81) OR=.957 (.50- 1.83) 
  No mechanical 
bowel preparation 
REFERENCE  
Use of oral 
antibiotics** 
OR=.548 (0.27-1.10) OR=.598 (0.29-1.23) 
  No oral antibiotics REFERENCE  
 
*Full cohort 
**Cohort that used mechanical bowel preparation 
***adjusted for characteristics that achieved p<0.05 individual associations with CDI 
in preliminary analyses:  
 
Bowel prep (in full cohort) - body mass index, preoperative functional status, type of 
resection, ASA status, congestive heart failure, history of myocardial infarction, acute 
renal failure, steroid use, bleeding disorder, transfusions, sepsis and transfer from 
healthcare facility. 
 
Use of oral antibiotics (in full cohort) - body mass index, sex, race, type of resection, 
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